{"study_id": 13062, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Echinacea extract, as part of an anti-inflammatory feed supplement, could reduce prolactin levels and improve fertility in lactating Merino ewes.", "results_summary": "The study found no significant differences in prolactin levels or fertility outcomes between the control and treatment groups, suggesting Echinacea had no measurable effect. Pregnancy rates were actually lower in the treatment group compared to controls.", "population_specificity": "Lactating Merino ewes", "effective_dosage": "60 ml of Stop Lactin\u00ae (containing Echinacea extract) administered once orally", "study_duration": "Single dose on day 0, with follow-up measurements over an unspecified period", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:29.656133+00:00"}
{"study_id": 13060, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the polyphenolic components of Echinacea purpurea flowers and leaves, including diurnal variations and morphological differences, to determine optimal harvesting times for maximizing antioxidant capacity.", "results_summary": "The study found that methanol extracts of flowers and leaves had the highest total phenolic and flavonoid content at 09:00 a.m., with chlorogenic acid and caffeic acid as predominant phenolic acids. Peak concentrations of these compounds occurred at 6:00 a.m., declining throughout the day, highlighting the importance of harvest timing for antioxidant potential.", "population_specificity": "Two-year-old Echinacea purpurea plants in full bloom.", "effective_dosage": "Not specified (extracts analyzed for content, not administered).", "study_duration": "Not specified (single-day harvest at varying times).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:29.703225+00:00"}
{"study_id": 187609, "supplement_id": 1094, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to analyze 20-OHE levels in dietary supplements, develop an analytical strategy for its detection and metabolites, and estimate its prevalence among elite athletes.", "results_summary": "Only 5 of 16 supplements contained detectable 20-OHE (up to 2.3 mg/capsule). 20-OHE and its metabolite were detectable in urine within hours of ingestion, with longer detection times for higher doses. Prevalence among athletes was 0.4%.", "population_specificity": "uPA(+/+)-SCID mice with humanized liver, a human volunteer, and elite athletes (n=1000).", "effective_dosage": "Low and high concentration supplements (exact dosages not specified).", "study_duration": "Detection times ranged from 48-96 hours post-ingestion.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:30.263525+00:00"}
{"study_id": 14163, "supplement_id": 1094, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the role of ecdysteroids in the development of *Schistosoma mansoni* and their potential as a target for therapy or immunization.", "results_summary": "The study found that ecdysteroids are produced during critical developmental stages of *S. mansoni*, correlate with host susceptibility, and decrease after schistomicide therapy. Immunization with an ecdysone-BSA complex reduced worm burden, and ecdysterone antibodies killed juvenile worms in vitro.", "population_specificity": "*Schistosoma mansoni*-infected vertebrates (rodents and humans, specifically infected children).", "effective_dosage": "Not specified", "study_duration": "Observations made up to 40 days postinfection; therapy effects noted 4 days post-administration.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:30.275044+00:00"}
{"study_id": 187611, "supplement_id": 1094, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to summarize the structural similarities between ecdysteroids and Vitamin D analogues and explore potential shared mechanisms of action, particularly regarding muscle function.", "results_summary": "The study highlights that ecdysteroids may increase muscle size and strength, similar to androgenic steroids but without binding to mammalian steroid receptors, suggesting a possible influence on signal transduction pathways. It also notes structural and functional parallels between ecdysteroids and 1,25D, implying potential overlapping effects on muscle function.", "population_specificity": "Not specified (abstract discusses general mammalian effects).", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:31.515591+00:00"}
{"study_id": 13059, "supplement_id": 1095, "safety_score": "65", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of E. purpurea in treating upper respiratory tract infections (URTI) and otitis media (OM) in children.", "results_summary": "E. purpurea significantly reduced URTI treatment duration, incidence, and antibiotic use, with some positive effects on OM incidence but not treatment duration. Adverse events were moderately increased but generally mild.", "population_specificity": "Children with URTI or OM.", "effective_dosage": "Not specified (varied by study).", "study_duration": "Not specified (varied by study).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:32.187187+00:00"}
{"study_id": 13063, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify compounds from Echinacea angustifolia that could inhibit Zika virus RNA-dependent RNA polymerase (RDRP) activity, potentially serving as antiviral agents.", "results_summary": "The study identified four E. angustifolia compounds (Echinacoside, Rutin, Echinacin, and Cynaroside) with strong binding affinity to ZIKV RDRP, favorable binding free energies, and robust hydrogen bond interactions, suggesting potential as antiviral inhibitors.", "population_specificity": "Computational study (no human or animal subjects).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:36.628728+00:00"}
{"study_id": 13064, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of an ELA blend (containing Echinacea purpurea) in preventing and alleviating URTI symptoms, as well as its antiviral and immunomodulatory effects.", "results_summary": "The ELA blend significantly reduced URTI incidence and throat-related symptoms, modulated cytokine production, and suppressed viral replication, demonstrating both immunomodulatory and antiviral effects.", "population_specificity": "61 participants prone to URTIs.", "effective_dosage": "Not specified in the abstract.", "study_duration": "60 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:37.445860+00:00"}
{"study_id": 13067, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to analyze the heterogeneity of Echinacea monopreparations available on the market and compare them with those used in clinical studies to assess consistency and standardization.", "results_summary": "The study found that Echinacea preparations on the market are highly heterogeneous in composition, making it difficult to generalize clinical study results. The legal framework and market presentation contribute to this inconsistency, highlighting the need for new studies based on market reality.", "population_specificity": "Not specified (market analysis of Echinacea preparations in Germany)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:37.858201+00:00"}
{"study_id": 13065, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to determine whether Echinacea extract syrup could improve lower respiratory tract outcomes in COVID-19 patients.", "results_summary": "The study found no significant differences between the Echinacea and control groups in lung involvement, cough symptoms, oxygen saturation, temperature, or respiratory rate. While white blood cell count decreased in the Echinacea group, arterial oxygen pressure improved in both groups without significant differences between them.", "population_specificity": "40 hospitalized COVID-19 patients in Iran.", "effective_dosage": "5 cubic centimeters (CC) of Imogen syrup three times daily.", "study_duration": "5 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:38.406828+00:00"}
{"study_id": 13068, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the mechanisms by which echinacea extracts modulate immune responses and their effects on bacterial and viral infections.", "results_summary": "Echinacea enhances immune cell activity, including macrophages and natural killer cells, and exhibits antibacterial and antiviral properties against pathogens like Streptococcus pneumoniae and herpes simplex virus. The study highlights its potential as a complementary treatment but notes variability in phytochemical content.", "population_specificity": "Not specified (general immune response and infection contexts).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:38.831421+00:00"}
{"study_id": 13071, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether echinacea supplementation has erythropoietic or ergogenic effects in athletes.", "results_summary": "The meta-analysis found small, non-significant positive effects on hemoglobin and hematocrit levels, but no statistically significant changes in erythropoietin or maximal oxygen uptake. The evidence base was limited.", "population_specificity": "Athletes (107 participants across 6 studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:39.614643+00:00"}
{"study_id": 13069, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether a combination of Centella asiatica, Echinacea purpurea, and Zingiber officinale extracts could prevent the deleterious effects of chronic social defeat stress in mice.", "results_summary": "The extract mix prevented stress-induced social aversion, memory impairment, mechanical and thermal allodynia, and reduced behavioral despair. It also modulated BDNF, TrkB, and cytokine expression in the brain and spinal cord.", "population_specificity": "Male mice exposed to chronic social defeat stress.", "effective_dosage": "Echinacea purpurea (20 mg/kg daily).", "study_duration": "3 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:40.556386+00:00"}
{"study_id": 13070, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the antiviral, immunomodulatory, and antioxidant effects of the ELA blend containing Echinacea purpurea (EP) on viral infection mechanisms.", "results_summary": "The ELA blend reduced inflammatory markers (IL1B, CXCL8, ICAM1, MCP1, RELA) and enhanced antioxidant gene expression (CAT, HMOX1, SOD1, SOD2). It also showed an 87.5% reduction in viral titer against HCoV-OC43, suggesting potential antiviral activity by blocking viral entry.", "population_specificity": "A549 cells and a 3D mucociliary tissue model (EpiAirway\u2122).", "effective_dosage": "Highest non-cytotoxic concentration (specific amount not stated).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:41.599185+00:00"}
{"study_id": 13072, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Echinacea purpurea polysaccharide (EPP) could prevent or alleviate ulcerative colitis (UC) in mice and to analyze its mechanism of action.", "results_summary": "Dietary supplementation with EPP significantly alleviated UC symptoms in mice, including colon length shortening, weight loss, and histopathological damage. EPP inhibited the TLR4/NF-\u03baB pathway, preserved intestinal barrier integrity, and altered gut microbiota and metabolism.", "population_specificity": "DSS-induced colitis mice", "effective_dosage": "200 mg/kg", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:44.654630+00:00"}
{"study_id": 13074, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the potential mechanism of Echinacea purpurea polysaccharide (EPP) intervention in hepatocellular carcinoma (HCC) and its effects on gut microbiota and inflammatory pathways.", "results_summary": "EPP mitigated liver injury, inhibited HCC proliferation, induced apoptosis, increased beneficial gut microbiota, repaired the intestinal barrier, and reduced inflammatory and migration factors by modulating the TLR4/NF-\u03baB pathway.", "population_specificity": "Mice with hepatocellular carcinoma (HCC).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:45.751927+00:00"}
{"study_id": 13073, "supplement_id": 1095, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to determine whether Echinacea could reduce the need for antibiotics by preventing respiratory tract infections (RTIs) and their complications, while also assessing its safety profile.", "results_summary": "Echinacea significantly reduced RTI occurrence, recurrent infections, complications, and antibiotic therapy days, with alcoholic extracts from freshly harvested Echinacea purpurea showing the strongest effects. Adverse events were equally frequent between Echinacea and control treatments.", "population_specificity": "5,652 subjects across 30 clinical trials.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:46.112305+00:00"}
{"study_id": 13075, "supplement_id": 1095, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Echinacea purpurea hydroethanolic extract (EchEE) could protect against bifenthrin-induced neurochemical and behavioral changes in rats.", "results_summary": "EchEE significantly reduced oxidative stress damage, modulated apoptotic and pro-inflammatory markers, and improved behavioral activities and neurotransmitter levels impaired by bifenthrin. The study concluded that EchEE attenuates brain dysfunction caused by pesticide exposure through its antioxidant properties.", "population_specificity": "Adult male albino rats", "effective_dosage": "465 mg/kg/day", "study_duration": "30 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:47.216838+00:00"}
{"study_id": 13076, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether essential oils from Echinacea purpurea contribute to its medicinal properties, particularly antimicrobial and immunomodulatory effects.", "results_summary": "The study identified 87 compounds in Echinacea essential oils, with germacrene D, \u03b1-phellandrene, and \u03b2-caryophyllene as major components. The oils showed antimicrobial activity against several bacteria (excluding Staphylococcus aureus) and immunomodulatory effects, including neutrophil calcium mobilization and chemotaxis suppression.", "population_specificity": "Human neutrophils (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:47.633540+00:00"}
{"study_id": 13078, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to provide an overview of mechanistic evidence for Echinacea's effects in treating uncomplicated, acute upper respiratory tract infections (URTI).", "results_summary": "The study found that Echinacea species likely act through immunomodulation, supporting its clinical effects in URTI treatment. However, detailed mechanistic evidence was limited compared to other herbs reviewed.", "population_specificity": "Not specified (mechanistic studies included in vitro, animal, and human studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:48.795994+00:00"}
{"study_id": 13077, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the combined cytoprotective, antioxidant, immunomodulating, and antiviral properties of an Echinacea purpurea and Humulus lupulus extract mixture (ECHOPvir) in preventing and treating viral respiratory diseases.", "results_summary": "The ECP/HOP mixture demonstrated promising multitarget bioactivity, including cytoprotective, antioxidant, immunomodulating, and antiviral effects, with enhanced activity compared to single extracts. Nrf2 activation appeared to play a key role in these cytoprotective properties.", "population_specificity": "Murine macrophages and airway cells (in vitro study).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:49.361265+00:00"}
{"study_id": 13079, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the immunomodulatory effects of a standardized Echinacea purpurea extract enriched with chicoric acid, both in vitro and in cyclophosphamide-induced immunosuppressed mice.", "results_summary": "The SEP extract demonstrated strong antioxidant activity, increased nitric oxide production, enhanced phagocytosis, and elevated cytokine release in RAW 264.7 cells. In mice, it improved immune organ indices, lymphocyte proliferation, serum cytokine levels, natural killer cell activity, and phagocytic index.", "population_specificity": "Male BALB/c mice (20-25 g) and RAW 264.7 cells.", "effective_dosage": "100 and 200 mg/kg body weight (oral) for mice; 200 and 400 \u00b5g/mL for in vitro studies.", "study_duration": "10 days (from day 5 to 14) for mice.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:51.873952+00:00"}
{"study_id": 13081, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to perform a phytochemical characterization of Echinacea purpurea roots and their extracts to identify biologically active substances and suitable extraction methods.", "results_summary": "The study found that Echinacea roots contain high levels of carbohydrates (45%) and proteins (20%), with water being the most effective solvent for extracting polysaccharides (8.87%). Ethanol and glycerol were effective for phenolic components, with glycerol being equally efficient as ethanol for caffeic acid derivatives.", "population_specificity": "Not specified (in vitro study on plant material)", "effective_dosage": "Not specified (extraction methods described)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:54.730651+00:00"}
{"study_id": 13080, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine how supplementing calves with Echinacea purpurea (EP) affects their blood immunity markers, health, intake, and growth.", "results_summary": "EP supplementation was associated with reduced inflammation and immunomodulation, evidenced by lower haptoglobin levels and segmented neutrophil counts, but only minor health and growth improvements were observed. Benefits were more pronounced when EP was fed throughout the entire milk-feeding period.", "population_specificity": "Male Holstein calves (n = 240) aged 5-14 days at arrival.", "effective_dosage": "3 g of dried EP extract per day, split over 2 milk feedings (either from day 14-28 or day 1-56).", "study_duration": "56 days (for the full supplementation group) or 14 days (for the partial supplementation group).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:55.416611+00:00"}
{"study_id": 13082, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the efficacy of EZC Pak (a combination of Echinacea, Zinc, and Vitamin C) with or without Vitamin D in reducing the duration and severity of non-specific upper respiratory infections (URIs) as an alternative to antibiotics.", "results_summary": "EZC Pak reduced illness duration by 1.39 days and symptom severity by 17.43% compared to placebo, with higher patient satisfaction. The addition of Vitamin D had no significant impact on outcomes.", "population_specificity": "360 patients across the United States with non-specific URIs.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Until symptoms resolved (exact duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:56.550524+00:00"}
{"study_id": 13085, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to understand the immune-regulating mechanism of Echinacea purpurea (EP) in hybrid snakehead fish by analyzing immune-related miRNAs in liver, spleen, and head kidney tissues.", "results_summary": "EP affected immune activities in fish via miRNA regulation, with varying numbers of differentially expressed miRNAs across tissues. Immune-related miRNA families, including those involved in innate and adaptive immune responses, were identified, and pathway analysis confirmed immune response targets.", "population_specificity": "Hybrid snakehead fish (Channa maculate\u2640 \u00d7 Channa argus \u2642)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:57.502523+00:00"}
{"study_id": 13086, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anti-inflammatory capacity of Echinacea purpurea extracts and identify the bioactive compounds responsible for this effect.", "results_summary": "Echinacea purpurea extracts and fractions significantly reduced pro-inflammatory cytokines and reactive oxygen/nitrogen species in human macrophages, with alkylamides identified as the primary bioactive compounds. The dichloromethanolic root extract (DE-R) and its alkylamide fraction (DE-R-F2) showed the strongest anti-inflammatory activity, likely through modulation of key signaling pathways.", "population_specificity": "Primary human monocyte-derived macrophages (in vitro study).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:58.606225+00:00"}
{"study_id": 13083, "supplement_id": 1095, "safety_score": "85", "efficacy_score": 75, "quality_score": 90, "study_goal": "The researchers aimed to compare the efficacy and safety of higher-dose Echinacea formulations (A and B) versus conventional lower-dose formulations (C and D) for treating respiratory tract infections (RTIs) in healthy adults.", "results_summary": "New higher-dose Echinacea formulations showed faster viral clearance (70% vs. 53%) and a trend toward quicker clinical recovery, though not statistically significant by day 10. Extrapolated analysis suggested significantly shorter mean time to remission (9.6 vs. 11.0 days). Safety profiles were similar, with one severe adverse event (hypersensitivity) noted.", "population_specificity": "Healthy adults (median age 32 years, 78% female) with RTIs.", "effective_dosage": "New formulations: 16,800 mg/day (days 1-3), 2,240-3,360 mg/day (afterward); conventional formulations: 2,400 mg/day.", "study_duration": "Up to 10 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:59.007594+00:00"}
{"study_id": 13087, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the chemical composition of Echinacea purpurea and propolis hydroalcoholic solution (EAP) and evaluate its antimicrobial activity against various bacterial strains.", "results_summary": "The study identified terpenes, sugars, and organic acids in EAP and demonstrated strong antimicrobial activity, reducing bacterial load after 48 hours, though bacterial motility remained unaffected.", "population_specificity": "Bacterial type strains, food isolates, and clinical isolates.", "effective_dosage": "Not specified", "study_duration": "48 hours (for motility assays)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:59.986937+00:00"}
{"study_id": 13090, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of Echinacea extract on gut microbiota and immune function in immunosuppressed ducks.", "results_summary": "Echinacea extract improved weight gain, immune organ indices, and cytokine levels in immunosuppressed ducks, while modulating gut microbiota by increasing beneficial bacteria and reducing harmful ones.", "population_specificity": "Immunosuppressed ducks", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:03.276877+00:00"}
{"study_id": 13089, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the protective effect of Echinacea purpurea extract (EE) on ulcerative colitis (UC) and explore the role of the complement system in its treatment.", "results_summary": "EE reduced weight loss and diarrhea in UC rats, improved intestinal epithelial barrier integrity, inhibited proinflammatory cytokines, promoted antioxidation, and suppressed the expression of key inflammatory markers (C3aR, CFB, CD55, TLR4, NLRP3).", "population_specificity": "Rats with TNBS-induced ulcerative colitis.", "effective_dosage": "Not specified.", "study_duration": "10 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:04.306235+00:00"}
{"study_id": 13088, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine optimal extraction conditions for Echinacea purpurea to maximize caffeic acid derivatives and radical scavenging activity, and evaluate its antioxidant, antiaging, and wound healing effects.", "results_summary": "The study found that glycerol extraction produced Echinacea extracts with strong radical scavenging, Fe2+ chelating, and antioxidant properties, as well as notable collagenase, elastase, and tyrosinase inhibition. The extracts also demonstrated significant hyaluronidase-inhibitory activity and promoted wound healing in HaCaT keratinocyte monolayers at low concentrations.", "population_specificity": "In vitro (HaCaT keratinocyte monolayers)", "effective_dosage": "2.5 \u03bcL extract/mL (for RSA-opt)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:04.515024+00:00"}
{"study_id": 13091, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the potential of Echinacea purpurea flower extracts to mitigate neurodegenerative effects induced by Aluminum chloride in a rat model and explore its mechanisms of action.", "results_summary": "The study found that Echinacea purpurea extracts (aqueous and alcoholic) inhibited cholinesterase, restored oxidative balance, reduced inflammatory cytokines (IL-6 & TNF-\u03b1), improved behavior, and decreased neuronal degeneration and amyloid plaques in the brain. The alcoholic extract showed greater potency in vivo, while the aqueous extract was more effective against COX-1, COX-2, and \u03b1-amylase in vitro.", "population_specificity": "Rat model with Aluminum chloride-induced neurobehavioral toxicity.", "effective_dosage": "250 mg/kg of aqueous and alcoholic extracts.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:07.651120+00:00"}
{"study_id": 13092, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to compare the potential ameliorative effects of Echinacea, ginger, and their combination on diabetic nephropathy in rats.", "results_summary": "Echinacea alone showed some improvement in diabetes-induced renal damage but was less effective than ginger alone or in combination with Echinacea. The combination treatment significantly reduced collagen fibers, apoptosis (caspase-3), and macrophage infiltration compared to Echinacea alone.", "population_specificity": "Adult male albino rats with experimentally induced diabetic nephropathy.", "effective_dosage": "100 mg/kg Echinacea orally for 30 days.", "study_duration": "30 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:07.773729+00:00"}
{"study_id": 13084, "supplement_id": 1095, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety and efficacy of Echinacea/Salvia lozenges in reducing symptoms and viral loads in patients with acute sore throat.", "results_summary": "The treatment was well tolerated, significantly reduced throat pain (48%) and tonsillopharyngitis symptoms (34%), and decreased viral loads by 62% after one lozenge and 96% after 4 days. No complicated infections or antibiotic treatments were required.", "population_specificity": "74 patients aged 13-69 years with acute sore throat symptoms (<48 hours).", "effective_dosage": "4,000 mg Echinacea purpurea extract and 1,893 mg Salvia officinalis extract daily, administered as five lozenges per day.", "study_duration": "4 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:08.458805+00:00"}
{"study_id": 13093, "supplement_id": 1095, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to assess the effectiveness of systemic Echinacea on clinical indices of oral lichen planus (OLP), particularly pain severity and lesion characteristics.", "results_summary": "Echinacea significantly reduced pain severity (VAS scores) and showed a notable difference in clinical symptoms compared to placebo, demonstrating its effectiveness as a complementary therapy for OLP. The study also noted that Echinacea was well-tolerated in short-term usage.", "population_specificity": "70 patients with erosive oral lichen planus (OLP).", "effective_dosage": "Echinacea tablets, 3 times a day (specific dosage amount not provided).", "study_duration": "35 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:09.710623+00:00"}
{"study_id": 13095, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the antiviral effects of Echinacea species (E. purpurea and E. angustifolia) against SARS-CoV-2 in vitro.", "results_summary": "Echinacea showed significant antiviral and virucidal effects against SARS-CoV-2, though less potent than H. perforatum or the H. perforatum-Echinacea mixture. Molecular simulation identified bioactive compounds in Echinacea that may contribute to its antiviral activity.", "population_specificity": "In vitro study using Vero E6 cells.", "effective_dosage": "Not specified.", "study_duration": "0-48 hours post-infection.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:11.465784+00:00"}
{"study_id": 13094, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the therapeutic potential of Echinacea purpurea extracts (rich in alkamides and polyphenols) in treating oxaliplatin-induced neuropathic pain by targeting the endocannabinoid system and counteracting redox imbalance.", "results_summary": "EP4-RE (alkamide-rich extract) showed dose-dependent anti-hyperalgesic effects, mediated by CB2 receptor activity, while EP4-RBU (polyphenol-rich extract) exhibited anti-neuropathic properties, primarily due to chicoric acid. Synergistic effects were observed for alkamides but not polyphenols.", "population_specificity": "In vivo model of oxaliplatin-induced neuropathic pain.", "effective_dosage": "EP4-RE (30 mg/kg), dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamide (18 mg/kg), EP4-RBU (30 mg/kg), chicoric acid (123 \u03bcg/kg).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:11.799642+00:00"}
{"study_id": 13097, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anti-coccidial effects of an herbal mixture containing Echinacea purpurea and Glycyrrhiza glabra in broiler chickens compared to toltrazuril.", "results_summary": "The herbal mixture significantly reduced negative performance and pathogenic effects of Eimeria spp., with results comparable to toltrazuril. The positive control group showed the poorest outcomes, while the herbal-treated group performed similarly to the drug-treated group.", "population_specificity": "Broiler chickens experimentally infected with mixed Eimeria spp.", "effective_dosage": "Echinacea purpurea Extract 2% (standardised to 4% total phenolic content based on chlorogenic acid).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:14.251776+00:00"}
{"study_id": 13096, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the hematological response of Magellanic penguins to Echinacea angustifolia and Avena sativa during the reproductive period, focusing on immune-related parameters.", "results_summary": "The study found that Echinacea angustifolia and Avena sativa treatment resulted in less marked changes in lymphocyte concentration and proportion compared to the control group, suggesting a potential immune-supportive effect during the breeding period. Significant effects were also observed in mean corpuscular volume (MCV) and heterophil proportions.", "population_specificity": "Magellanic penguins (Spheniscus magellanicus) in a zoological park setting.", "effective_dosage": "Echinacea angustifolia 6cH and Avena sativa 6cH (specific frequency not mentioned).", "study_duration": "Duration of intervention not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:15.008614+00:00"}
{"study_id": 13099, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of Echinacea purpurea (EP) in mitigating oxidative stress and nephrotoxicity induced by hexavalent chromium (Cr(VI)) in male rats.", "results_summary": "EP treatment significantly reduced oxidative stress markers, improved kidney function biomarkers, suppressed inflammatory reactions, and ameliorated kidney tissue damage caused by Cr(VI). The study demonstrated EP's nephroprotective effects through biochemical, molecular, and histopathological improvements.", "population_specificity": "Male Wistar rats", "effective_dosage": "50 mg/kg, once daily", "study_duration": "3 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:17.181960+00:00"}
{"study_id": 13100, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the efficacy of Echinacea supplementation on the remission of cervical low-grade squamous intraepithelial lesions (L-SIL/CIN-1) in women with HPV-related pathologies.", "results_summary": "Echinacea supplementation combined with vaginal hyaluronic acid significantly improved cervical lesion clearance, histological, colposcopic, and vaginal parameters at 6 and 12 months, but no effects were seen after 3 months. The Echinacea-alone group showed less improvement than the combination group but still outperformed the hyaluronic acid-alone group.", "population_specificity": "Reproductive-aged women with cervical low-grade squamous intraepithelial lesions (L-SIL/CIN-1).", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:17.802882+00:00"}
{"study_id": 13098, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the efficacy of a vegetal mixture containing Echinacea purpurea in counteracting neuroinflammation and its associated symptoms in a mouse model.", "results_summary": "The vegetal mixture, including Echinacea, effectively reduced neuroinflammation-induced symptoms such as thermal and mechanical allodynia, motor impairments, memory loss, and depressive-like behavior, though it did not affect anhedonia. The mixture also rebalanced glial cell activation, complement proteins, and inflammatory cytokines in the CNS.", "population_specificity": "Mice with systemic neuroinflammation induced by LPS.", "effective_dosage": "20 mg kg-1 of Echinacea purpurea (as part of the mixture).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:19.129111+00:00"}
{"study_id": 13102, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to explore the effects of Echinacea purpurea polysaccharide (EPP) on gut microbiota and hepatic metabolism in the context of alcoholic liver disease (ALD).", "results_summary": "EPP reversed alcohol-induced gut microbiota disturbances, increased beneficial bacteria, promoted n-butyric acid production, and improved hepatic metabolites and metabolic pathways, suggesting it alleviates ALD via the gut-liver axis.", "population_specificity": "Study focused on the effects of EPP in the context of alcoholic liver disease (specific population not detailed in abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:20.105646+00:00"}
{"study_id": 13101, "supplement_id": 1095, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of Echinacea purpurea in preventing and treating respiratory tract infections, particularly SARS-CoV-2 infections.", "results_summary": "Echinacea reduced the risk of viral respiratory infections, including SARS-CoV-2, and significantly decreased virus load and fever days during acute episodes, though it did not significantly reduce overall symptom severity.", "population_specificity": "120 healthy volunteers (male and female, aged 18-75 years).", "effective_dosage": "2,400 mg daily for prevention; 4,000 mg daily for acute treatment.", "study_duration": "3 prevention cycles (2, 2, and 1 month) with 1-week breaks between cycles; acute treatment lasted up to 10 days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:20.733678+00:00"}
{"study_id": 13104, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate Echinacea's effectiveness in preventing viral respiratory tract infections, including coronaviruses, and reducing symptom severity and viral loads.", "results_summary": "Echinacea significantly reduced the incidence of enveloped virus infections and coronavirus detections in adults and children, lowered symptom severity, and decreased viral loads by 98.5% in nasal secretions.", "population_specificity": "Adults (N = 755) and children aged 4-12 years (N = 203).", "effective_dosage": "2400 mg daily (adults), 1200 mg daily (children).", "study_duration": "4 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:22.986396+00:00"}
{"study_id": 13103, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Echinacea purpurea ethanol extract nanoparticles (Nano-EE) could effectively ameliorate osteoarthritis (OA) symptoms in obese rats compared to unencapsulated extract.", "results_summary": "Nano-EE reduced leptin content, MMPs, cytokines, NF-\u03baB, and iNOS production while increasing collagen II expression, alleviating OA pain, and reducing cartilage proteoglycan loss. The encapsulated form was more effective than unencapsulated EE at a lower dosage.", "population_specificity": "Obese Sprague-Dawley rats with induced osteoarthritis.", "effective_dosage": "Different doses (specific amounts not stated) administered via oral gavage.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:23.262572+00:00"}
{"study_id": 13105, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the immunomodulatory effects of Echinacea purpurea extract in mice subjected to forced swimming exercise.", "results_summary": "Echinacea intake increased MHC II levels, CD4+ T cells, Th1 cytokines, NK cell activity, B cell proliferation, leukocyte counts, and immunoglobulin levels, suggesting improved immune response.", "population_specificity": "C57BL/6N mice exposed to forced swimming exercise.", "effective_dosage": "50, 100, and 200 mg/kg body weight.", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:23.394966+00:00"}
{"study_id": 13109, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to characterize the genome-wide immunomodulatory effects of a standardized Echinacea purpurea extract (Echinaforce\u00ae) in THP1 monocytes, focusing on antiviral innate immunity pathways.", "results_summary": "The study found that Echinaforce\u00ae triggers antiviral innate immunity pathways, including tonic IFN signaling, activation of pattern recognition receptors, and DNA hypermethylation at repeat elements, which may enhance protection against viral infections like common cold coronaviruses and SARS-CoV-2.", "population_specificity": "THP1 monocytes (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:29.079655+00:00"}
{"study_id": 13110, "supplement_id": 1095, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to determine whether Echinacea could prevent viral respiratory tract infections (RTIs), reduce secondary bacterial complications, and lower antibiotic usage in children.", "results_summary": "Echinacea significantly reduced cold days, RTI episodes, antibiotic prescriptions, and complications compared to vitamin C, with fewer adverse events reported. It also notably prevented influenza and enveloped virus infections.", "population_specificity": "Children aged 4-12 years.", "effective_dosage": "400 mg freshly harvested Echinacea purpurea alcoholic extract (Echinaforce\u00ae Junior tablets), three times daily.", "study_duration": "Two 2-month prevention periods separated by a 1-week treatment break.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:30.474315+00:00"}
{"study_id": 13106, "supplement_id": 1095, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to prepare niosome-encapsulated Echinacea angustifolia extract and evaluate its efficacy against multidrug-resistant Klebsiella pneumoniae strains.", "results_summary": "The encapsulated Echinacea extract showed up to 16-fold higher antibacterial activity against multidrug-resistant K. pneumoniae compared to the free extract, with negligible cytotoxicity against human foreskin fibroblasts. The niosomes demonstrated controlled drug release over 72 hours and stability for at least 2 months at 4 and 25 \u00b0C.", "population_specificity": "Multidrug-resistant Klebsiella pneumoniae strains and human foreskin fibroblasts (in vitro).", "effective_dosage": "Not specified", "study_duration": "72 hours (drug release study), 2 months (stability study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:30.567755+00:00"}
{"study_id": 13107, "supplement_id": 1095, "safety_score": "85", "efficacy_score": 78, "quality_score": 72, "study_goal": "The researchers aimed to review Echinacea's chemical composition, pharmacological effects on hepatopathy, and safety profile.", "results_summary": "Echinacea demonstrated significant hepatoprotective effects by modulating multiple signaling pathways and showed immunomodulatory and anti-inflammatory properties. Preclinical and clinical studies indicated it was well-tolerated with no major safety concerns.", "population_specificity": "Preclinical models and clinical trial participants (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:30.648629+00:00"}
{"study_id": 13108, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether Echinacea root extracts exhibit cannabinoid receptor activity and reduce inflammatory pain through endocannabinoid system activation, comparing effects across species and genotypes.", "results_summary": "The study found that Echinacea root extracts showed varying CB receptor agonist activity, predicted by phytochemistry, and produced dose-dependent analgesic effects in a rat model of inflammatory pain, partially reversed by CB receptor antagonists.", "population_specificity": "Rats (Hargreaves model of chronic inflammatory pain)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:30.997015+00:00"}
{"study_id": 13112, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the presence, localization, and potential functions of endophytic microorganisms in Echinacea purpurea cypselas (fruits) and their role in seed germination.", "results_summary": "The study found that Echinacea purpurea cypselas contain endocellular bacteria in cotyledons and fungal components in the perianth, with microbiome-deprived seeds showing reduced germination ability. The bacterial community was resistant to antibiotics and an antimicrobial-producing strain, suggesting a symbiotic relationship.", "population_specificity": "Echinacea purpurea cypselas (fruits)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:32.075946+00:00"}
{"study_id": 13113, "supplement_id": 1095, "safety_score": "80", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate Echinacea's potential as a therapeutic agent for COVID-19 by targeting infection, immunity, and inflammation, focusing on its antiviral and immunomodulatory properties.", "results_summary": "The study suggests Echinacea, particularly E. purpurea, may modulate virus entry, internalization, and replication, and exhibits immunomodulatory and anti-inflammatory effects, making it a plausible candidate for COVID-19 management. However, further evidence-based studies are needed to confirm its efficacy.", "population_specificity": "Not specified (general human population implied).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:35.622809+00:00"}
{"study_id": 13111, "supplement_id": 1095, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Echinacea, combined with Zingiber officinale, could alleviate clinical symptoms and reduce hospitalization rates in suspected COVID-19 outpatients.", "results_summary": "The intervention group showed greater improvement in coughing, dyspnea, and muscle pain compared to the control group, though no significant difference was found in other symptoms or hospitalization rates.", "population_specificity": "Suspected COVID-19 outpatients (n=100, with 50 in the intervention group).", "effective_dosage": "Tablet Rucoldup I tds (specific dosage not detailed).", "study_duration": "7 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:35.693778+00:00"}
{"study_id": 13114, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to develop and validate a UPLC method to quantify caffeic acid derivatives in commercial dried extracts of Echinacea purpurea and assess their variability.", "results_summary": "The study successfully developed a validated UPLC method to measure caffeic acid derivatives (caftaric acid, chicoric acid, chlorogenic acid) in Echinacea extracts, revealing significant variability in their concentrations across commercial samples. The findings highlight the need for standardization of these active markers in commercial extracts.", "population_specificity": "Commercial dried extracts of Echinacea purpurea", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:38.694824+00:00"}
{"study_id": 13115, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the effects of Echinacea purpurea root extract on lung cancer cell growth, apoptosis, and its potential regulatory role via the CB2 receptor.", "results_summary": "Echinacea purpurea extract reduced A549 lung cancer cell viability in a time- and dose-dependent manner, induced early apoptosis, increased ROS levels, and activated caspase 3, with effects mediated by CB2 receptor activity.", "population_specificity": "A549 lung cancer cells (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Time-dependent effects observed, but exact duration not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:40.024045+00:00"}
{"study_id": 13116, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the effects of Echinacea polysaccharide (EP) on lipopolysaccharide (LPS)-induced acute kidney injury (AKI) by assessing its anti-inflammatory, antioxidative, and immunomodulatory properties.", "results_summary": "EP significantly reduced LPS-induced kidney injury, inflammation, and oxidative stress by downregulating inflammatory markers and inhibiting the mitogen-activated protein kinase signaling pathway. It also improved renal function markers and cell viability in vitro.", "population_specificity": "Mice with LPS-induced AKI and HBZY-1 cells (a mouse kidney cell line).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:40.118108+00:00"}
{"study_id": 13117, "supplement_id": 1095, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety profile and treatment benefits of Echinacea (Echinaforce Junior tablets) in children with acute cold and flu symptoms.", "results_summary": "Echinacea was well tolerated (96% positive physician ratings), reduced cold episode duration by up to 1.7 days with higher dosage, and contributed to a low antibiotic prescription rate (4.6%). Nine out of 10 episodes resolved fully within 10 days.", "population_specificity": "Children aged 4-12 years with acute cold and flu symptoms.", "effective_dosage": "1200 mg (three tablets daily) or 2000 mg (five tablets daily) of Echinacea extract.", "study_duration": "Treatment administered during cold episodes (average duration 7.5 days).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:40.834372+00:00"}
{"study_id": 13118, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Echinacea Polysaccharides (EP) could alleviate LPS-induced lung injury by inhibiting inflammation, apoptosis, and the TLR4/NF-\u03baB signaling pathway.", "results_summary": "EP reduced lung damage, inflammatory cell infiltration, and cytokine release (TNF-\u03b1, IL-6, IL-1\u03b2) in both murine models and RAW 264.7 cells, while also suppressing apoptosis and modulating TLR4/NF-\u03baB pathway activity.", "population_specificity": "Murine models (mice) and RAW 264.7 cells (macrophage cell line).", "effective_dosage": "5 mg/kg or 10 mg/kg in mice; 100 \u03bcg/ml in RAW 264.7 cells.", "study_duration": "Not specified for mice; 1-hour EP pretreatment followed by 24-hour LPS incubation in cells.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:41.620964+00:00"}
{"study_id": 13119, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficiency of traditional maceration methods using water and ethanol with glycerol-water mixtures for extracting caffeic acid derivatives from Echinacea purpurea and to develop an optimized ultrasound-assisted extraction method.", "results_summary": "Glycerol-water mixtures were as effective as ethanol-water mixtures for extracting caffeic acid derivatives, and ultrasound-assisted extraction using glycerol-water mixtures achieved higher yields of phenolic acids in shorter time. The extracts demonstrated notable antiradical properties and could be directly used in cosmetics or oral pharmaceutical formulations.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified (extraction conditions: glycerol 90% (m/m), temperature 70 \u00b0C, ultrasound power 72 W, time 40 min, ascorbic acid 0 mg/mL)", "study_duration": "Not specified (extraction time: 40 min for optimized ultrasound-assisted extraction)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:43.425601+00:00"}
{"study_id": 13121, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the virucidal and antiviral potential of Echinacea purpurea (Echinaforce\u00ae) against various coronaviruses, including SARS-CoV-2, in vitro.", "results_summary": "Echinaforce\u00ae irreversibly inactivated HCoV-229E at 3.2 \u03bcg/ml IC50 and showed virucidal activity against SARS-CoV-1, MERS-CoV, and SARS-CoV-2 at similar concentrations. Pre- and post-infection treatment had limited effects, but pre-treated respiratory epithelium showed protective effects in an organotypic model.", "population_specificity": "In vitro cell lines and organotypic respiratory cell culture systems.", "effective_dosage": "3.2 \u03bcg/ml IC50 for HCoV-229E, 50 \u03bcg/ml for SARS-CoV-2.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:46.316057+00:00"}
{"study_id": 13125, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to identify new compounds from Echinacea purpurea root cultures with potential antiresorptive effects, specifically focusing on their ability to regulate osteoclast differentiation and survival.", "results_summary": "The study isolated three new compounds, with echinalkamide (compound 1) showing significant inhibitory effects on osteoclast differentiation, proliferation, and bone resorption, while also suppressing osteoclast-specific gene expression via the MAPK-c-Fos-NFATC1 pathway.", "population_specificity": "In vitro (cell culture) study, not human or animal subjects.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:49.638883+00:00"}
{"study_id": 13122, "supplement_id": 1095, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety and efficacy of Echinacea in reducing the duration and severity of acute respiratory infections (ARI) and its potential role in modulating immune responses, including cytokine storm.", "results_summary": "Echinacea supplementation may decrease the severity and duration of ARI when taken at symptom onset, with few reported adverse events. It appears to reduce pro-inflammatory cytokines linked to cytokine storm, but no studies exist on its effects in COVID-19-like conditions.", "population_specificity": "General population with acute respiratory infections (no specific subgroup mentioned).", "effective_dosage": "Standardized amounts of E. purpurea or a combination of E. purpurea and E. angustifolia (exact dosage not specified).", "study_duration": "Up to 4 months in some trials.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:49.887689+00:00"}
{"study_id": 13124, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 65, "study_goal": "The researchers aimed to determine the antibacterial effects of Echinacea purpurea, both alone and as part of the HMPE formula, against Staphylococcus epidermidis and Escherichia coli.", "results_summary": "Echinacea purpurea alone did not inhibit the growth of either Staphylococcus epidermidis or Escherichia coli. The HMPE formula, which included Echinacea, showed limited antibacterial activity against S. epidermidis but was less effective than H. canadensis alone.", "population_specificity": "In-vitro bacterial cultures (Staphylococcus epidermidis and Escherichia coli).", "effective_dosage": "15 \u00b5l of E. purpurea tincture.", "study_duration": "Single exposure (disc diffusion assay).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:50.062941+00:00"}
{"study_id": 13123, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to examine callus embryogenesis in Echinacea purpurea using various combinations of growth regulators and supplements to optimize somatic embryogenesis and plantlet production.", "results_summary": "The study found that the highest embryogenesis (100%) and embryonic regeneration occurred with combined BA + NAA treatments supplemented with activated charcoal, coconut milk, and casein hydrolysate. The best growth characteristics and chlorophyll content were observed in media containing lower NAA levels combined with these supplements.", "population_specificity": "In vitro callus cultures of Echinacea purpurea.", "effective_dosage": "BA (3, 4, 5 mg L-1), NAA (0.1, 0.2, 0.5 mg L-1), activated charcoal (1 g L-1), coconut milk (50 ml L-1), casein hydrolysate (50 mg L-1).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:51.902488+00:00"}
{"study_id": 13126, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of combined Azithromycin and Echinacea versus Azithromycin alone in reducing tonsillitis attacks and symptom severity in children with recurrent tonsillitis.", "results_summary": "The study found that the combination of Azithromycin and Echinacea significantly reduced the number of tonsillitis attacks and symptom severity compared to Azithromycin alone, with no significant difference between groups receiving any prophylaxis.", "population_specificity": "Children with recurrent tonsillitis (100 patients per group).", "effective_dosage": "5 ml oral suspension of Echinacea, 3 times daily for 10 consecutive days every month.", "study_duration": "6 consecutive months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:52.112656+00:00"}
{"study_id": 13127, "supplement_id": 1095, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to determine whether a standardized Echinacea angustifolia root extract could reduce anxiety in individuals with elevated anxiety scores.", "results_summary": "The study found that Echinacea significantly reduced state anxiety scores compared to placebo, with effects persisting during the washout period. Trait anxiety improvements were less pronounced but still better than placebo in high-anxiety individuals, while depression and stress scores remained unaffected.", "population_specificity": "Volunteers scoring above 45 points on the state or trait subscale of the State Trait Anxiety Inventory (STAI).", "effective_dosage": "40 mg twice daily", "study_duration": "7 days of treatment followed by a 3-week washout period", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:52.329154+00:00"}
{"study_id": 13128, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether intracellular phosphate supply and extracellular phosphate limitation could enhance chicoric acid production in Echinacea purpurea hairy roots.", "results_summary": "The study found that overexpression of the AtPAP26 gene and phosphate limitation significantly increased chicoric acid production (16-fold) and biomass in transgenic hairy roots compared to non-transgenic controls. The approach also upregulated genes involved in chicoric acid biosynthesis.", "population_specificity": "Echinacea purpurea hairy roots (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:54.759004+00:00"}
{"study_id": 13130, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 65, "study_goal": "The researchers aimed to determine the effect of Echinacea purpurea root extract on immune cell survival and cytokine production in activated murine splenocytes.", "results_summary": "Echinacea purpurea root extract did not affect splenocyte survival or IL-2 production, modestly increased IFN-\u03b3 levels, and significantly increased TNF production in a dose-dependent manner, suggesting immunomodulatory effects.", "population_specificity": "Murine (mouse) splenocytes activated with concanavalin A (ConA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:58.445295+00:00"}
{"study_id": 13131, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the occurrence and potential bioactivities of phylloxanthobilins in Echinacea purpurea, particularly their antioxidant properties.", "results_summary": "The study identified six phylloxanthobilins in Echinacea purpurea leaves, demonstrating potent in vitro antioxidant activity, intracellular ROS scavenging ability, and prevention of oxidative stress. These findings suggest phylloxanthobilins may contribute to Echinacea's pharmacological effects.", "population_specificity": "Human endothelial kidney cells (in vitro study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:58.754336+00:00"}
{"study_id": 13129, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the immunological effects of Echinacea purpurea polysaccharide (EPP) and its sulfated form (sEPP) on chicken bone marrow-derived dendritic cells (chBM-DCs).", "results_summary": "Both EPP and sEPP enhanced immune responses in chBM-DCs, with sEPP showing superior immunoregulatory effects, including increased surface marker expression, lymphocyte proliferation, and cytokine modulation (higher IFN-\u03b3, lower IL-4 and IL-10).", "population_specificity": "Chicken bone marrow-derived dendritic cells (chBM-DCs).", "effective_dosage": "Three dosages of sEPP (specific amounts not stated).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:59.045643+00:00"}
{"study_id": 13133, "supplement_id": 1095, "safety_score": "85", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to assess the safety and efficacy of Echinacea preparations in preventing and treating upper respiratory tract infections (URTIs).", "results_summary": "The study found that Echinacea might have a preventative effect on URTIs (risk ratio 0.78) but did not significantly reduce their duration. No significant safety risks were identified in the short term.", "population_specificity": "Otherwise healthy individuals of any age and sex.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:00.133264+00:00"}
{"study_id": 13132, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Immulant, containing Echinacea purpurea extract, could protect against cisplatin-induced immunotoxicity in rats.", "results_summary": "Cisplatin caused significant immunotoxicity, but co-administration of Immulant substantially improved immunotoxicological indices, including leukocytic count, phagocytic activity, and humoral immunity. The herbal formulation demonstrated protective effects against cisplatin-induced damage to lymphoid tissue.", "population_specificity": "Mature albino rats", "effective_dosage": "150 mg/kg orally once daily", "study_duration": "2 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:01.108459+00:00"}
{"study_id": 13134, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate whether Echinacea (HPVADL18\u00ae) could reduce relapse rates of genital condylomatosis after laser therapy.", "results_summary": "The study found that Echinacea significantly reduced relapse rates, particularly in patients over 25, with effects observed in both men and women. Relapse incidence was higher in cases of extended condylomatosis.", "population_specificity": "Patients with genital condylomatosis treated with Co2 Laser therapy.", "effective_dosage": "200 mg dry extracts of Echinacea Purpurea roots plus E. Angustifolia, administered orally.", "study_duration": "4 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:01.540684+00:00"}
{"study_id": 13135, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine the effects of nitrogen fertilizer and irrigation levels on biochemical reactions, enzyme activities, and yield in Echinacea purpurea.", "results_summary": "The study found that nitrogen sources improved physiological reactions, particularly peroxidase, polyphenol oxidase, and carotenoid metabolism, with optimal results observed under 50% water depletion and 80 kg nitrogen or a combination of nitroxin and 40 kg nitrogen. Drought stress increased enzyme activities, while nitrogen deficiency reduced greenness.", "population_specificity": "Echinacea purpurea plants grown in a research field in Iran.", "effective_dosage": "Nitrogen treatments included 0 kg N ha-1, nitroxin, 40 kg N ha-1, 40 kg N ha-1 + nitroxin, and 80 kg N ha-1.", "study_duration": "2 years (2013-2015).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:05.500604+00:00"}
{"study_id": 13136, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of Echinacea purpurea as a nutritional supplement in fish feed for disease prevention and antioxidant benefits.", "results_summary": "The study found that Echinacea-enriched fish feed retained antioxidant properties after high-temperature processing and could serve as a natural source of polyphenols and nutritive ingredients, potentially aiding in disease prevention caused by oxidative stress.", "population_specificity": "Fish (specific species not mentioned)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:06.315842+00:00"}
{"study_id": 13137, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to develop an efficient method for the preparative separation and purification of chicoric acid from Echinacea purpurea to enhance its utilization in pharmaceutical applications.", "results_summary": "The study successfully identified HPD100 as the optimal macroporous adsorption resin for chicoric acid separation, achieving a 15.8-fold increase in purity (from 4% to 63%). The method was noted for its high efficiency and simplicity.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:07.172714+00:00"}
{"study_id": 13138, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the antipruritic effects and cosmetic properties of Echinacea purpurea root extract in emulsions and shampoo for adults suffering from pruritus.", "results_summary": "The study found that Echinacea-containing products significantly reduced erythema, dryness, and pruritus in participants, with high percentages reporting improvement (e.g., 93% for body pruritus with w/o emulsion). The effects were consistent across different formulations (w/o, o/w, shampoo).", "population_specificity": "Adults with pruritus of the body or scalp.", "effective_dosage": "Not specified.", "study_duration": "2 weeks (w/o emulsion), 4 weeks (o/w emulsion and shampoo).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:08.271404+00:00"}
{"study_id": 13141, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of Echinacea in preventing and treating the common cold, based on evidence from multiple studies.", "results_summary": "Prophylactic treatment with Echinacea extract (2400 mg/day) over 4 months appeared beneficial for preventing/treating the common cold, though further studies are needed.", "population_specificity": "Not specified (general population inferred).", "effective_dosage": "2400 mg/day", "study_duration": "4 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:08.968453+00:00"}
{"study_id": 13140, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of Echinacea on the treatment of aphthous ulcers, focusing on lesion count, pain intensity, ulcer improvement, and recurrence rate.", "results_summary": "The study found that Echinacea significantly reduced the number of lesions, pain intensity, and recurrence rate while improving ulcer healing over six months compared to the control group.", "population_specificity": "50 patients with minor aphthous ulcers.", "effective_dosage": "3 tablets per day for five weeks.", "study_duration": "Five weeks of intervention, with six months of follow-up.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:09.167010+00:00"}
{"study_id": 13139, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to analyze the immunomodulatory and anti-inflammatory activity of Echinacea spp. and explore its potential as a complementary therapy.", "results_summary": "The abstract highlights Echinacea's potential immunomodulatory and anti-inflammatory effects, suggesting it could supplement existing therapies, but does not provide specific outcome data.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:10.699227+00:00"}
{"study_id": 13120, "supplement_id": 1095, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "To determine the effects of Echinacea angustifolia DC extract (Ea-AcOEt) on breast cancer cell lines, including cytotoxicity, cell cycle arrest, and apoptosis, as well as its safety and potential synergistic effects with paclitaxel.", "results_summary": "The Ea-AcOEt extract demonstrated cytotoxic activity against breast cancer cells (MDA-MB-231 and MCF-7) without affecting normal breast cells (MCF-10). It induced G1 phase cell cycle arrest and caspase-mediated apoptosis, showed no genotoxicity, and exhibited a synergistic effect with paclitaxel in vitro.", "population_specificity": "Breast cancer cell lines (MDA-MB-231, MCF-7) and normal breast cells (MCF-10), as well as rodents for in vivo safety assessment.", "effective_dosage": "IC50 values: 28.18 \u00b1 1.14 \u00b5g/ml (MDA-MB-231), 19.97 \u00b1 2.31 \u00b5g/ml (MCF-7); in vivo safety tested at 2,000 mg/kg.", "study_duration": "Not specified in the abstract.", "interactions": "Synergistic effect with paclitaxel noted in vitro.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:12.891249+00:00"}
{"study_id": 13143, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether Echinacea purpurea could protect against restraint stress-induced immunosuppression in mice by assessing immune function markers.", "results_summary": "Echinacea significantly restored immune parameters, including splenocyte proliferation, NK cell activity, T lymphocyte subsets, and cytokine levels, which were suppressed by restraint stress.", "population_specificity": "BALB/c mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:14.743518+00:00"}
{"study_id": 13144, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of echinacea and chlorhexidine mouthwash solutions on reducing oral microbial flora in intubated ICU patients.", "results_summary": "Echinacea significantly reduced oral microbial flora (p < 0.0001) and was more effective than chlorhexidine after 4 days (p < 0.001).", "population_specificity": "Intubated ICU patients aged 18-65 years.", "effective_dosage": "Not specified", "study_duration": "4 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:15.020016+00:00"}
{"study_id": 13142, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine if Echinacea purpurea extract could mitigate the toxic side effects of magnetic nanoparticles (MNP) in testicular tissues.", "results_summary": "Short-term EP extract administration slightly reduced MNP toxicity, while extended exposure restored INSL3 expression and testosterone levels to near control levels and reduced collagen and elastin accumulation caused by MNP. The ameliorative effect is attributed to EP's antioxidant properties.", "population_specificity": "Testicular tissues in a controlled experimental setting (not human subjects).", "effective_dosage": "Not specified", "study_duration": "Short-term and extended exposure (specific durations not provided)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:15.294094+00:00"}
{"study_id": 13146, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate how Echinacea purpurea regulates efflux transporters ABCB1 and ABCG2 and identify specific microRNAs involved in their post-transcriptional regulation.", "results_summary": "Echinacea increased ABCB1 and ABCG2 mRNA levels in HepG2 cells, with miR-655-3p identified as a key regulator of ABCG2 via binding to its 3'-UTR. The study confirmed EP's role in modulating ABCG2 expression through miR-655-3p downregulation.", "population_specificity": "Human hepatoblastoma HepG2 cells", "effective_dosage": "50 \u00b5g/mL methanolic extract of EP", "study_duration": "12 hours", "interactions": "EP-mediated drug interactions via ABCG2 regulation were suggested but not detailed.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:18.600546+00:00"}
{"study_id": 13145, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effects of an ethanolic E. purpurea root extract and the alkylamide A15 on mast cell activation to understand Echinacea's traditional anti-inflammatory uses.", "results_summary": "A15 significantly inhibited mast cell degranulation, calcium influx, and mediator release (e.g., histamine, TNF-\u03b1, PGE2) in multiple cell lines, with similar effects observed for high-alkylamide E. purpurea fractions. These findings suggest Echinacea may mitigate allergic and inflammatory responses.", "population_specificity": "In vitro studies using bone marrow-derived mast cells (BMMCs), RBL-2H3 cells, RAW 264.7 macrophages, and Jurkat T cells.", "effective_dosage": "100\u00b5M A15 (specific extract dosages not detailed).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:19.051967+00:00"}
{"study_id": 13148, "supplement_id": 1095, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the volatile components, toxicity, anti-inflammatory, and analgesic activities of Echinacea essential oil in rodents.", "results_summary": "The essential root oil showed no toxicity at 5000 mg/kg, significantly reduced inflammation in carrageenan-induced edema, and reduced pain in acetic acid-induced writhing models. The chemical composition of leaf and root oils varied, with germacrene D and other compounds identified as major components.", "population_specificity": "Rodents (mice and rats)", "effective_dosage": "100-200 mg/kg for anti-inflammatory and analgesic tests; 1000 mg/kg for analgesic test; up to 5000 mg/kg for toxicity", "study_duration": "Not specified (acute toxicity and single-dose efficacy tests)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:20.435122+00:00"}
{"study_id": 13150, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect of a polysaccharide-enriched extract of Echinacea purpurea on macrophage polarization.", "results_summary": "The study found that the extract activated macrophages, increased M1-related markers and cytokines, and enhanced phagocytic and bactericidal activity, dependent on JNK signaling pathways.", "population_specificity": "Macrophages (in vitro study)", "effective_dosage": "100 \u00b5g/mL", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:22.466093+00:00"}
{"study_id": 13152, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the potential applicability of Echinacea for managing respiratory tract infections in Hajj travelers.", "results_summary": "The review found considerable evidence supporting Echinacea's effectiveness in preventing and treating respiratory tract infections, though some findings were controversial. The study suggests that standardized products with adequate doses or combinations with other immune-stimulants in well-designed trials would be beneficial.", "population_specificity": "Hajj travelers", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:22.798196+00:00"}
{"study_id": 13151, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to analyze the effect of Echinacea purpurea aqueous extract on acute and prolonged Toxoplasma gondii infections in mice.", "results_summary": "The study found that E. purpurea extract significantly reduced tachyzoites in peritoneal fluid and liver imprints in RH strain-infected mice and increased brain cysts in ME 49 strain-infected mice, suggesting protective activities against T. gondii.", "population_specificity": "Swiss mice infected with different T. gondii strains.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:22.810915+00:00"}
{"study_id": 13149, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effect of Echinacea purpurea extract, alone and in combination with meglumine antimoniate, on treating cutaneous leishmaniasis caused by Leishmania major in mice.", "results_summary": "The study found that Echinacea extract alone or in combination with meglumine antimoniate reduced lesion sizes compared to the control group, but the differences were not statistically significant. The combination therapy did not show significant effectiveness against L. major in the tested doses.", "population_specificity": "BALB/C mice infected with Leishmania major.", "effective_dosage": "100-200 mg/kg of Echinacea extract (orally), 10-20 mg/kg of meglumine antimoniate.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:23.002658+00:00"}
{"study_id": 13147, "supplement_id": 1095, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to assess the anti-inflammatory effects and symptom alleviation of Echinacea purpurea-derived alkylamides in atopic eczema (AE) by targeting cannabinoid (CB)-2 receptors.", "results_summary": "Echinacea extract significantly reduced pro-inflammatory cytokines in keratinocytes, improved SCORAD scores in AE patients, and enhanced epidermal lipid barrier function, including increased ceramide EOS and cholesterol levels.", "population_specificity": "Patients with atopic eczema (AE).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Day 15 (Clinical trial 3).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:26.671792+00:00"}
{"study_id": 13155, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to chemically examine fungal endophytes in Echinacea purpurea and identify compounds with cytokine-suppressive activity.", "results_summary": "The study identified 16 secondary metabolites from fungal endophytes, with five compounds showing TNF-\u03b1 suppression in murine macrophages without significant cytotoxicity. This suggests potential anti-inflammatory effects linked to Echinacea's traditional use.", "population_specificity": "Murine macrophage-type cells (RAW 264.7)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:26.791533+00:00"}
{"study_id": 13153, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to determine the proliferative effect of an ethanolic blend of Echinacea angustifolia and Echinacea purpurea on cancer cell lines (HeLa and QBC-939) and human vein epithelial cells (HUVEC).", "results_summary": "The Echinacea blend showed inhibitory effects on HeLa and QBC-939 cancer cells at varying concentrations, with up to 100% inhibition in HeLa cells. It also promoted HUVEC growth by up to 800% at higher concentrations, suggesting potential benefits for neurodegenerative diseases.", "population_specificity": "Cancer cell lines (HeLa and QBC-939) and human vein epithelial cells (HUVEC).", "effective_dosage": "12.5 \u03bcg/mL to 200 \u03bcg/mL.", "study_duration": "Not specified.", "interactions": "Potential interference with chemotherapy drugs (5-fluorouracil and Cisplatin).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:29.180735+00:00"}
{"study_id": 13156, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the safety and efficacy of Echinacea purpurea for prophylactic treatment of the common cold and assess its risk-benefit ratio in long-term use.", "results_summary": "The study found that Echinacea purpurea reduced the total number of cold episodes, days with colds, and colds requiring additional medication. It also inhibited virally confirmed colds and showed increased preventive effects with better compliance.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not specified in the abstract.", "study_duration": "4 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:30.326496+00:00"}
{"study_id": 187613, "supplement_id": 1095, "safety_score": "60", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers aimed to assess the prevalence and implications of preoperative herbal medication use, including Echinacea, and its potential interactions with anesthetic drugs.", "results_summary": "The study found that Echinacea is commonly used among preoperative patients, but 50-70% fail to disclose its use to physicians. It may interact with anesthetic medications, though specific effects of Echinacea were not detailed.", "population_specificity": "Preoperative patients in the U.S.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Potential interactions with anesthetic medications, though specifics for Echinacea were not detailed.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:31.345317+00:00"}
{"study_id": 13158, "supplement_id": 1095, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the antitussive effect of Kan Jang\u00ae (containing Echinacea purpurea) with placebo and bromhexine in patients with upper respiratory infections.", "results_summary": "Kan Jang\u00ae relieved cough more effectively than placebo and showed faster improvement than bromhexine by the third and fourth days of treatment, with a good tolerability and safety profile.", "population_specificity": "Patients aged 18-65 with non-complicated upper respiratory infections (common cold).", "effective_dosage": "30 ml/day (762 mg genuine extracts, including 0.8 mg/ml chicoric acid from Echinacea).", "study_duration": "5 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:31.485423+00:00"}
{"study_id": 13157, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the immunomodulatory effects of Echinacea purpurea extract on dendritic cell (DC) generation and differentiation in vitro and in vivo.", "results_summary": "Echinacea purpurea extract significantly reduced the yield of CD83-expressing DCs when monocytes were treated prior to TNF-\u03b1 exposure, but had no significant effect when applied simultaneously with TNF-\u03b1. In vivo, Echinacea treatment did not significantly alter CD83 or CD11c expression in murine splenic DCs.", "population_specificity": "Human peripheral blood monocytes and murine splenic dendritic cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:31.486892+00:00"}
{"study_id": 187615, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to study the oral pharmacokinetics of Echinacea angustifolia DC. and Zingiber officinale Roscoe extracts and examine their immunomodulatory and anti-inflammatory properties through gene expression profiling.", "results_summary": "The bioactive components were rapidly absorbed, and the study provided evidence supporting the immunomodulatory and anti-inflammatory properties of the combined extracts. Gene expression analysis revealed transcriptional remodeling in peripheral blood mononuclear cells.", "population_specificity": "10 healthy volunteers", "effective_dosage": "5 mg Echinacea angustifolia DC. and 25 mg Zingiber officinale Roscoe per softgel capsule", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:31.887109+00:00"}
{"study_id": 187617, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study aimed to assess the effectiveness of vitamin C, not Echinacea, in preventing and reducing the duration of upper respiratory tract infections (URTI) in children.", "results_summary": "The study found no preventive effects of vitamin C on URTI incidence but noted a reduction in the duration of URTI symptoms. It concluded that vitamin C supplementation is justified, especially in children under 6 years and those with frequent URTIs.", "population_specificity": "Children aged 3 months to 18 years without chronic infection.", "effective_dosage": "Not mentioned (study focused on vitamin C, not Echinacea).", "study_duration": "Not mentioned (study focused on vitamin C, not Echinacea).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:35.825253+00:00"}
{"study_id": 187618, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "To determine if echinacea-based dietary supplements at two doses (8,000 mg/day and 16,000 mg/day) improve erythropoietin (EPO) and blood markers related to aerobic capacity and VO2max in endurance-trained athletes, and to assess sex differences.", "results_summary": "The study found no significant improvement in VO2max or blood markers for endurance-trained men or women taking echinacea, with no difference between placebo and regular dose. The double dose showed no effect, and no blood parameter changes were observed.", "population_specificity": "Endurance-trained men and women (45 participants total).", "effective_dosage": "8,000 mg/day (regular dose) and 16,000 mg/day (double dose).", "study_duration": "35 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:36.630140+00:00"}
{"study_id": 187619, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 10, "quality_score": 85, "study_goal": "The researchers aimed to determine if Echinacea purpurea supplementation improves maximal oxygen uptake (VO2max) and related blood parameters in trained endurance runners.", "results_summary": "The study found that Echinacea supplementation (8,000 mg/day for 6 weeks) did not improve VO2max, hematocrit, or hemoglobin levels in trained endurance runners compared to placebo.", "population_specificity": "Trained endurance runners (16 participants: 9 ECH, 7 placebo).", "effective_dosage": "8,000 mg per day.", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:37.646066+00:00"}
{"study_id": 187620, "supplement_id": 1095, "safety_score": "85", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Echinacea purpurea affects the pharmacokinetics of the CYP3A4 substrate docetaxel in cancer patients.", "results_summary": "The study found that Echinacea purpurea supplementation did not significantly alter the pharmacokinetics of docetaxel, with no statistically significant changes in area under the plasma concentration-time curve, elimination half-life, or maximum plasma concentration. The authors concluded that Echinacea can be safely combined with docetaxel at the tested dose.", "population_specificity": "Ten evaluable cancer patients.", "effective_dosage": "20 oral drops three times daily.", "study_duration": "14 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:39.083609+00:00"}
{"study_id": 187623, "supplement_id": 1095, "safety_score": "90", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to investigate whether Echinacea purpurea interacts with the antiretroviral drug darunavir-ritonavir in HIV-infected patients.", "results_summary": "The study found that Echinacea was well tolerated and did not significantly affect overall darunavir pharmacokinetics, though some individuals showed decreased darunavir concentrations. No dose adjustment was deemed necessary, but individual monitoring was suggested.", "population_specificity": "HIV-infected patients receiving antiretroviral therapy including darunavir-ritonavir.", "effective_dosage": "500 mg every 6 hours.", "study_duration": "14 days.", "interactions": "Potential interaction with darunavir-ritonavir, though not clinically significant overall.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:39.682223+00:00"}
{"study_id": 187621, "supplement_id": 1095, "safety_score": "90", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate whether Echinacea purpurea interacts with etravirine, an HIV medication, by assessing pharmacokinetic changes when coadministered.", "results_summary": "The study found that Echinacea did not significantly alter etravirine pharmacokinetics, with geometric mean ratios close to 1 for key parameters, suggesting no need for dose adjustments. Echinacea was well tolerated with no adverse effects reported.", "population_specificity": "HIV-infected patients on stable antiretroviral therapy with etravirine.", "effective_dosage": "500 mg every 8 hours.", "study_duration": "14 days.", "interactions": "None mentioned beyond the studied interaction with etravirine.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:40.217998+00:00"}
{"study_id": 187622, "supplement_id": 1095, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the effects of 4 weeks of oral Echinacea supplementation on erythropoietin (EPO), red blood cell count, running economy, and VO2max.", "results_summary": "Echinacea supplementation significantly increased EPO levels at 7, 14, and 21 days, improved VO2max, and enhanced running economy by reducing submaximal VO2 during exercise.", "population_specificity": "24 men aged 24.9 \u00b1 4.2 years, height 178.9 \u00b1 7.9 cm, weight 87.9 \u00b1 14.6 kg, body fat 19.3 \u00b1 6.5%.", "effective_dosage": "8,000 mg\u00b7d(-1) (5 \u00d7 400 mg \u00d7 4 times per day).", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:41.523736+00:00"}
{"study_id": 13935, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the neuroprotective effects of Ecklonia cava extract (EE) in amyloid beta-induced cognitive deficit mice, focusing on its potential to prevent or treat Alzheimer's disease.", "results_summary": "EE improved learning and memory, reduced oxidative stress, enhanced mitochondrial function, modulated synaptic proteins, and regulated apoptosis and inflammation pathways in A\u03b2-induced mice. It also increased BDNF production, suggesting potential benefits for Alzheimer's disease prevention and treatment.", "population_specificity": "A\u03b2-induced cognitive deficit mice (animal model).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:44.100334+00:00"}
{"study_id": 13936, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the anti-obesity effects of Ecklonia cava ethyl acetate extract (EC-ETAC) on adipogenesis, lipolysis, and adipose browning via the HO-1/Nrf2 pathway in 3T3-L1 preadipocytes.", "results_summary": "EC-ETAC significantly inhibited adipogenic transcription factors and lipogenesis-related proteins while enhancing lipolytic markers and adipose browning-related proteins, suggesting its role in reducing lipid accumulation and oxidative stress. These effects were mediated through the HO-1/Nrf2 pathway.", "population_specificity": "3T3-L1 preadipocytes (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:46.220448+00:00"}
{"study_id": 13937, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Ecklonia cava extract (ECE) and its active ingredient PHB could prevent nanoplastics-induced premature vascular senescence and dysfunction.", "results_summary": "ECE and PHB mitigated senescence-associated \u03b2-galactosidase activity, reduced oxidative stress, restored cell proliferation, and improved vascular dysfunction by upregulating endothelial nitric oxide synthase expression.", "population_specificity": "Porcine coronary arteries and porcine coronary endothelial cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:46.671480+00:00"}
{"study_id": 13939, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine if co-treatment with phlorotannin (PT) and extracellular vesicles (EVE) from Ecklonia cava could inhibit UV-induced melanogenesis by reducing oxidative stress and suppressing the TXNIP/NLRP3/IL-18 pathway.", "results_summary": "Co-treatment with PT and EVE reduced oxidative stress, suppressed the TXNIP/NLRP3/IL-18 pathway, decreased melanogenesis-related signals, and restored basement membrane components in UV-exposed keratinocytes and animal skin.", "population_specificity": "UV-exposed keratinocytes and animal skin models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:48.778144+00:00"}
{"study_id": 13938, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the impact of Ecklonia cava-derived extracellular vesicles (EV-EC) and phlorotannin (PT) on skin rejuvenation by assessing their effects on oxidative stress, inflammatory markers, and extracellular matrix degradation.", "results_summary": "Treatment with EV-EC and PT reduced oxidative stress, decreased expression of TNF-\u03b1, MAPK, NF-\u03baB, AP-1, and MMPs, and increased HSP70 expression in senescent keratinocytes and aged mice, leading to improved collagen accumulation and skin elasticity. Sequential PT/EV-EC treatment showed more significant effects than individual treatments.", "population_specificity": "In vitro senescent keratinocytes and in vivo aged mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:49.326631+00:00"}
{"study_id": 13940, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether crude polysaccharides from Ecklonia cava (ECC_CPS) could enhance the proliferation and differentiation of Hanwoo muscle satellite cells (HMSCs) for cultured meat production.", "results_summary": "ECC_CPS significantly increased cell viability, proliferation-related markers (MYF5, MYOD), and differentiation markers (MYH2, MYH7, MYOG), while also boosting cell migration activity via the HGF/MET and FAK pathways.", "population_specificity": "Hanwoo muscle satellite cells (HMSCs) in vitro.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:49.457884+00:00"}
{"study_id": 13941, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anti-tumor activity of an aqueous extract of Ecklonia Cava (AEC) against colon carcinoma in a syngeneic mouse model.", "results_summary": "AEC demonstrated significant anti-tumor effects, including reduced tumor volume and weight, increased apoptosis, suppressed cell proliferation, and inhibited metastasis in CT26 colon cancer cells. Phlorotannin (PT), a primary active compound in AEC, also showed increased cytotoxicity and apoptosis in treated cells.", "population_specificity": "CT26 tumor-bearing BALB/cKorl syngeneic mice", "effective_dosage": "Not specified", "study_duration": "Five weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:50.981944+00:00"}
{"study_id": 13934, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of Ecklonia cava-derived extracellular vesicles (EVEs) in reducing TPA-induced skin inflammation by targeting the TLR4/NF-\u03baB/NLRP3 inflammasome pathway.", "results_summary": "EVEs reduced TPA-induced inflammation in human keratinocytes and mouse ear skin by decreasing the expression of TLR4, NF-\u03baB, NLRP3 inflammasome components, and pyroptosis-related factors, while also alleviating symptoms like edema, redness, and neutrophil infiltration.", "population_specificity": "Human keratinocytes and mouse ear skin.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:51.695000+00:00"}
{"study_id": 13943, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the therapeutic potential and mechanism of dieckol (DK) from Ecklonia cava in preventing AGE-induced renal damage in diabetic nephropathy.", "results_summary": "DK demonstrated antiglycation properties by inhibiting AGE production, reducing oxidative stress, suppressing apoptosis, and competitively inhibiting AGE-RAGE interactions, suggesting potential for treating diabetic nephropathy.", "population_specificity": "Mouse glomerular mesangial cells", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:54.002952+00:00"}
{"study_id": 13942, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Ecklonia cava extract could mitigate neuroinflammation and neurodegeneration in mice under chronic inflammatory conditions.", "results_summary": "E. cava reduced pro-inflammatory cytokine levels in blood and brain, decreased activity of inflammation-related markers (NF-kB, STAT3), and lowered neurodegenerative disease markers (glial fibrillary acidic protein, beta-amyloid) in the cerebrum and hippocampus.", "population_specificity": "Mice with LPS-induced chronic inflammation.", "effective_dosage": "Not specified", "study_duration": "19 days pretreatment + 1 week exposure to E. cava with LPS", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:55.385221+00:00"}
{"study_id": 13944, "supplement_id": 1096, "safety_score": "90", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the acute effects of Ecklonia cava extract on postprandial blood glucose and insulin levels in prediabetic patients, as well as assess any associated side effects.", "results_summary": "The study found that a single dose of 600 mg Ecklonia cava significantly lowered postprandial blood glucose at 90 and 120 minutes compared to placebo, with no significant differences in postprandial insulin levels or discomfort symptoms between groups.", "population_specificity": "20 prediabetic patients in Saudi Arabia with no other health complications.", "effective_dosage": "600 mg single dose.", "study_duration": "Acute effect investigation (single dose).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:55.608181+00:00"}
{"study_id": 13945, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the anti-asthma mechanism of a bioprocessed functional food made from Ecklonia cava and shiitake mushroom mycelia.", "results_summary": "The bioprocessed Ecklonia cava inhibited mast cell degranulation and IgE production in vitro and reduced asthma symptoms in mice by suppressing inflammatory and immune-related substances, restoring Th1/Th2 balance, and increasing IL-10 levels. Lung tissue histology showed reduced airway thickening and inflammation.", "population_specificity": "Mice induced with asthma using alumina and ovalbumin (OVA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:58.074925+00:00"}
{"study_id": 13946, "supplement_id": 1096, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to investigate the anti-obesity properties of Ecklonia cava 70% ethanol extract, focusing on its effects on adipocyte differentiation and weight reduction in high-fat diet-induced obese rats.", "results_summary": "E. cava suppressed pre-adipocyte differentiation in vitro and significantly reduced body weight, organ weight (especially liver), and adipose tissue in obese rats. It also lowered liver-related biomarkers and modulated adipogenic and lipogenic gene expression, indicating anti-obesity effects.", "population_specificity": "High-fat diet-induced obese rats (animal model).", "effective_dosage": "125, 250, and 500 mg/kg.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:58.730934+00:00"}
{"study_id": 13948, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether phlorotannins from Ecklonia cava could alleviate chronic constipation in rats by examining stool parameters, gastrointestinal motility, and related mechanisms.", "results_summary": "The study found that Ecklonia cava-derived phlorotannins significantly improved stool parameters, gastrointestinal motility, intestinal structure, water channel expression, hormone secretion, and fecal microbiota in constipated rats.", "population_specificity": "SD rats with loperamide-induced constipation", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:59.114937+00:00"}
{"study_id": 13947, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anti-obesity effects of Ecklonia Cava (ECC) and its purified fucoidan fractions (ECFs) in vitro and in vivo, focusing on lipid accumulation and energy expenditure.", "results_summary": "ECC and ECFs significantly reduced lipid accumulation in 3T3-L1 adipocytes and in high-fat diet-induced obese mice, lowering body weight, serum lipid content, and adipose tissue mass. ECC also upregulated thermogenic proteins UCP1 and UCP3 in brown adipose tissue, suggesting enhanced energy expenditure.", "population_specificity": "Differentiated 3T3-L1 adipocytes (in vitro) and high-fat diet-induced obese mice (in vivo).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:59.526824+00:00"}
{"study_id": 13949, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Ecklonia cava-extracted fucoidan (ECF) could function as a mucosal adjuvant to enhance anti-cancer immunity in the lungs when administered intranasally.", "results_summary": "Intranasal ECF administration activated dendritic cells, NK cells, and T cells in mice, enhancing the anti-cancer effects of anti-PD-L1 antibodies against lung tumors. The effects were mediated by dendritic cells and required cytotoxic T lymphocytes and NK cells.", "population_specificity": "C57BL/6 and BALB/c mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:00.049564+00:00"}
{"study_id": 13951, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of Ecklonia cava fucoidan (ECF) on natural killer (NK) cell activation and its potential anti-cancer immunity in mice.", "results_summary": "ECF increased NK cell numbers in the spleen, strongly activated NK cells, and effectively prevented CT-26 carcinoma cell infiltration in the lungs in an NK cell-dependent manner. It also had the most potent effect on splenic dendritic cells (DC) among the tested fucoidans.", "population_specificity": "BALB/c mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:04.089800+00:00"}
{"study_id": 13950, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the anti-inflammatory effects of Ecklonia cava extract (ECE) on human gingival fibroblasts and its potential to mitigate tissue destruction and bone resorption in chronic periodontitis.", "results_summary": "ECE significantly reduced inflammatory gene expressions (COX-2, IL-6, MMPs, chemokines) and ROS production in LPS-stimulated cells, suppressed NF-\u03baB signaling, and improved alveolar bone resorption in a rat model of periodontitis.", "population_specificity": "Human gingival fibroblasts (HGF-1) and ligature-induced chronic periodontitis rat model.", "effective_dosage": "100 \u03bcg/mL (in vitro), 400 mg/kg (in vivo).", "study_duration": "8 weeks (in vivo).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:04.438108+00:00"}
{"study_id": 13952, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antioxidative, neuroprotective, and anti-apoptotic effects of Ecklonia cava extract (ECE), phlorotannin-rich extract (ECPE), and the phlorotannin dieckol on neuronal PC-12 cells.", "results_summary": "ECPE and ECE demonstrated significant antioxidant capacities, reduced intracellular oxidative stress, and improved cell viability in a dose-dependent manner. ECPE was more effective than ECE in reducing pro-apoptotic proteins and apoptosis in PC-12 cells.", "population_specificity": "Neuronal PC-12 cells (in vitro study).", "effective_dosage": "Not specified (dose-dependent effects observed).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:04.980237+00:00"}
{"study_id": 13953, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether tannin-enriched extracts of Ecklonia cava (TEE) could regulate oxidative balance and improve laxative activity in a chronic constipation model.", "results_summary": "TEE treatment significantly improved oxidative stress markers (ROS, SOD, Nrf2), stool parameters, gastrointestinal transit, and muscarinic cholinergic regulation in constipated rats. It also restored histopathological structure, mucin secretion, and gastrointestinal hormone levels.", "population_specificity": "Sprague-Dawley (SD) rats with loperamide-induced constipation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:06.885672+00:00"}
{"study_id": 13954, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the immunostimulatory and anticancer activities of fucoidan extracted from Ecklonia cava (ECF) in mice.", "results_summary": "ECF activated dendritic cells in vitro and in vivo, enhanced antigen-specific T cell responses, and suppressed tumor growth in mice when combined with antigens. The combination treatment also inhibited CT-26 carcinoma growth through antigen-specific immunity.", "population_specificity": "Mice (bone marrow-derived dendritic cells and splenic DCs in vivo)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:07.100106+00:00"}
{"study_id": 13955, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the antiallergic effects of eckol isolated from Ecklonia cava using mast cells and a mouse model of anaphylaxis.", "results_summary": "Eckol inhibited IgE/BSA-induced mast cell degranulation, reduced cytokine and chemokine production, and attenuated allergic reactions in mice, suggesting potential therapeutic benefits for allergic disorders.", "population_specificity": "Mouse bone marrow-derived cultured mast cells (BMCMC) and BALB/c mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:07.643413+00:00"}
{"study_id": 13957, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether eckol, a bioactive compound from Ecklonia Cava, could protect against TNF-\u03b1/IFN-\u03b3-induced skin inflammation in vitro.", "results_summary": "Eckol significantly suppressed pro-inflammatory cytokines and chemokines and inhibited the activation of MAPKs and NF-\u03baB signaling pathways in HaCaT cells, demonstrating protective effects against skin inflammation.", "population_specificity": "HaCaT cells (human keratinocyte cell line)", "effective_dosage": "25, 50, and 100 \u00b5g/ml", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:08.488084+00:00"}
{"study_id": 13956, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of Ecklonia cava extract (ECE) on inflammation, leptin resistance, and fat deposition in a diet-induced obese model.", "results_summary": "ECE reduced inflammation, attenuated leptin resistance, increased lipolysis, and showed antiadiposity effects in obese subjects. It also decreased expression of inflammation-related receptors (TLR4, RAGE) and improved leptin receptor expression.", "population_specificity": "Diet-induced obese model (animal study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:08.627168+00:00"}
{"study_id": 13960, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the osteoblastogenesis-promoting effects of phlorofucofuroeckol A (PFF-A) isolated from Ecklonia cava in bone formation.", "results_summary": "PFF-A enhanced osteoblast proliferation, alkaline phosphatase activity, extracellular mineralization, and upregulated key osteoblastogenesis-related proteins (ALP, BMP-2, osteocalcin, \u03b2-catenin) in murine and human cell models.", "population_specificity": "Murine pre-osteoblast cell line MC3T3-E1 and human bone marrow-derived mesenchymal stem cells (huBM-MSCs).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:13.696138+00:00"}
{"study_id": 13958, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antioxidant capacity and neuroprotective effects of a phlorotannin-rich extract from Ecklonia cava (PEEC) in vitro.", "results_summary": "PEEC demonstrated high antioxidant capacity and neuroprotective effects in PC-12 and SH-SY5Y cells against oxidative damage, reduced intracellular oxidative stress, and inhibited acetylcholinesterase and butyrylcholinesterase in a dose-dependent manner.", "population_specificity": "In vitro cell lines (PC-12 and SH-SY5Y).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:13.764323+00:00"}
{"study_id": 13959, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Ecklonia cava extracts, particularly specific phlorotannins, could attenuate tubular epithelial cell death induced by hypoxia/reoxygenation (H/R) injury and identify the most effective phlorotannin.", "results_summary": "PPB (pyrogallol phloroglucinol-6,6-bieckol) most effectively reduced HMGB1 release, inhibited TLR4/RAGE signaling, decreased inflammatory cytokines (TNF-\u03b1, IL-6), and suppressed cell death pathways (Erk, JNK, p38) in both pre- and post-hypoxia treatments. The results suggest PPB could be a novel therapeutic target for renal H/R injury.", "population_specificity": "Tubular epithelial cells (TCMK-1 cell line) in vitro.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:15.405066+00:00"}
{"study_id": 13961, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to examine the anti-inflammatory effects of Ecklonia cava extract and its major polyphenolic constituent, dieckol, on PM10-induced oxidative stress and inflammation in keratinocytes.", "results_summary": "E. cava extract and dieckol partially reversed PM10-induced decreases in cell viability and attenuated PGE2 production and the expression of inflammatory genes (COX-1, COX-2, mPGES-1, and mPGES-2). These findings suggest potential anti-inflammatory benefits against airborne PM.", "population_specificity": "HaCaT keratinocytes (human skin cells) exposed to PM10.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:16.694375+00:00"}
{"study_id": 13965, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of Ecklonia cava extract on hormonal balance and ovarian function in rats with letrozole-induced PCOS.", "results_summary": "E. cava extract restored regular estrus cycles, normalized hormone levels (testosterone, estrogen, LH, FSH, AMH), and reduced polycystic ovary symptoms in rats. Transcriptional and translational analysis showed increased Ar and Esr2 levels in treated rats.", "population_specificity": "Letrozole-induced PCOS female rats.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:17.183961+00:00"}
{"study_id": 13962, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anti-inflammatory effects of Ecklonia cava ethanol extract (ECE) on Porphyromonas gingivalis-induced inflammation in RAW 264.7 cells and ligature-induced periodontitis in rats.", "results_summary": "ECE reduced nitric oxide and prostaglandin E2 levels, downregulated pro-inflammatory cytokines, upregulated HO-1/Nrf-2 signaling, and decreased NF-\u03baB translocation. In rats, ECE administration reduced gingival inflammation, tooth mobility, and alveolar bone loss while lowering RANKL/osteoprotegerin ratios.", "population_specificity": "RAW 264.7 cells (mouse macrophages) and rats with ligature-induced periodontitis.", "effective_dosage": "100 \u03bcg/mL (in vitro), 400 mg/kg (in vivo).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:17.746661+00:00"}
{"study_id": 13963, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of major phlorotannins from Ecklonia cava as multi-target inhibitors of BACE1 and AChE for Alzheimer's disease treatment.", "results_summary": "The study found that phlorotannins, particularly 8,8'-bieckol, showed potent inhibitory effects on BACE1 and AChE, with 8,8'-bieckol exhibiting the strongest inhibition. Kinetic and in silico docking analyses supported their potential as dual-target inhibitors for Alzheimer's disease.", "population_specificity": "In vitro study (no human or animal subjects specified).", "effective_dosage": "IC50 values of 1.62 \u00b1 0.14 \u00b5M (BACE1) and 4.59 \u00b1 0.32 \u00b5M (AChE) for 8,8'-bieckol.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:18.369778+00:00"}
{"study_id": 13964, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the neuroprotective effects of phlorotannins from Ecklonia cava, particularly their anti-apoptotic and anti-inflammatory properties, against A\u03b225-35-induced damage in PC12 cells.", "results_summary": "Dieckol showed the highest neuroprotective effects by reducing oxidative stress, mitochondrial dysfunction, and caspase activation, while all three phlorotannins inhibited proinflammatory cytokine production and downregulated NF-\u03baB pathway enzymes. Dieckol also suppressed p38, ERK, and JNK activation, indicating strong anti-inflammatory potential.", "population_specificity": "PC12 cells (a rat adrenal pheochromocytoma cell line)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:19.428015+00:00"}
{"study_id": 13967, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of four major polyphenols from Ecklonia cava on monocyte-associated vascular inflammation and dysfunctions.", "results_summary": "PPB significantly inhibited monocyte migration, reduced inflammatory macrophage differentiation, protected against endothelial cell death, and decreased vascular smooth muscle cell proliferation and migration. The study found all four compounds effective, but PPB showed the most promise for treating vascular dysfunction.", "population_specificity": "In vitro (cell-based study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:21.999096+00:00"}
{"study_id": 13966, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Ecklonia cava extract (ECE) could inhibit osteoclast differentiation and bone resorption, potentially offering therapeutic benefits for osteoclast-associated disorders.", "results_summary": "ECE significantly inhibited RANKL-induced osteoclast differentiation and bone resorption, suppressed NF-\u03baB and MAPK signaling, downregulated osteoclast-specific genes, and reduced oxidative stress during osteoclastogenesis.", "population_specificity": "RAW 264.7 cells (a murine macrophage cell line)", "effective_dosage": "100 \u03bcg/ml", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:22.435638+00:00"}
{"study_id": 13968, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the inhibitory effects of minor phlorotannin derivatives from Ecklonia cava on \u03b1-glucosidase activity, a target for type 2 diabetes treatment.", "results_summary": "The study found that phlorotannin derivatives from Ecklonia cava inhibited \u03b1-glucosidase with IC50 values ranging from 2.3 to 59.8 \u03bcM, demonstrating both competitive and non-competitive inhibition mechanisms. Molecular simulation confirmed ligand-receptor binding conformations, suggesting potential for diabetes treatment.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified (IC50 values provided in \u03bcM)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:24.496639+00:00"}
{"study_id": 13970, "supplement_id": 1096, "safety_score": "90", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate the acute toxicity, subchronic toxicity, and genotoxicity of enzymatic Ecklonia cava extract to assess its safety for human consumption.", "results_summary": "The study found no adverse effects in rats and dogs at doses up to 3000 mg/kg BW, with no observed toxicity in body weight, organ function, or genotoxicity. The no-observed-adverse-effect level was determined to be 3000 mg/kg/day for rats.", "population_specificity": "Rats and dogs", "effective_dosage": "Up to 3000 mg/kg BW", "study_duration": "13 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:25.599825+00:00"}
{"study_id": 13969, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the anti-obesity effects of enzyme-treated Ecklonia cava extract (EEc) in mice with high-fat diet-induced obesity.", "results_summary": "EEc supplementation significantly reduced body weight, liver weight, white adipose tissue, and serum/hepatic triglyceride levels while improving lipid profiles and metabolic markers in obese mice. The extract also modulated key adipogenic and lipogenic proteins, suggesting anti-obesity potential.", "population_specificity": "C57BL/6N mice with high-fat diet-induced obesity.", "effective_dosage": "5, 25, or 150 mg/kg/day EEc.", "study_duration": "10 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:25.815065+00:00"}
{"study_id": 13971, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Ecklonia cava polyphenol extract (ECPE) improves renal damage in high-fat diet-induced obese mice by regulating energy metabolism, oxidative stress, and inflammation.", "results_summary": "ECPE treatment reduced markers of lipid accumulation, inflammation, and oxidative stress while upregulating proteins linked to renal energy metabolism, suggesting protective effects against obesity-induced kidney damage.", "population_specificity": "High-fat diet-induced obese mice", "effective_dosage": "100 or 500 mg/kg/day", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:26.354932+00:00"}
{"study_id": 13972, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anti-diabetic effects of phloroglucinol from Ecklonia cava, focusing on blood glucose control and hepatic glucose production regulation.", "results_summary": "Phloroglucinol improved glucose tolerance in mice on a high-fat diet and inhibited hepatic glucose production by reducing PEPCK and G6Pase expression, likely via AMPK\u03b1 pathway modulation.", "population_specificity": "Male C57BL/6J mice fed a high-fat diet and mouse primary hepatocytes/HepG2 cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:26.978581+00:00"}
{"study_id": 13973, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the inhibitory effects of enzyme-treated Ecklonia cava (EEc) extract on adipogenesis in 3T3-L1 adipocytes and its impact on adipogenesis-related gene expression.", "results_summary": "The EEc extract inhibited adipogenesis by reducing C/EBP\u03b1 expression and decreasing adipogenesis-related gene expression (SREBP-1c, A-FABP, FAS, adiponectin). It showed comparable inhibition of glucose utilization and triglyceride accumulation to Garcinia cambogia at lower concentrations.", "population_specificity": "3T3-L1 adipocytes (in vitro study)", "effective_dosage": "50 \u00b5g/ml EEc extract", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:28.911552+00:00"}
{"study_id": 13975, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the prebiotic effects of Ecklonia cava on lactic acid bacteria growth, its antibacterial activity against fish pathogens, and its protective role in a zebrafish infection model.", "results_summary": "Ecklonia cava enhanced the growth of lactic acid bacteria, exhibited antibacterial effects against fish pathogens, and improved survival in zebrafish infected with Edwardsiella tarda by modulating inflammatory responses.", "population_specificity": "Zebrafish (in vivo) and bacterial cultures (in vitro)", "effective_dosage": "Dose-dependent effects noted, but specific amounts not detailed", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:30.940210+00:00"}
{"study_id": 13974, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 35, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the protective effects of Ecklonia cava polyphenol extract (ECP) against cisplatin-induced ototoxicity in cochlear cells.", "results_summary": "A 25 \u03bcM dose of ECP showed temporary otoprotective effects at 24 hours, but this effect disappeared by 72 hours. Other doses of ECP did not demonstrate protective effects at either time point.", "population_specificity": "Mouse-derived House Ear Institute Organ of Corti (HEI-OC1) cochlear cells.", "effective_dosage": "1, 10, and 25 \u03bcM doses of ECP.", "study_duration": "24 and 72 hours.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:31.260028+00:00"}
{"study_id": 13976, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of increasing dietary levels of Ecklonia cava on growth performance, nutrient digestibility, serum immunoglobulins, cecal microflora, and intestinal morphology in weanling pigs.", "results_summary": "Increasing Ecklonia cava supplementation linearly improved average daily gain and gross energy digestibility, increased beneficial Lactobacillus spp., reduced harmful Escherichia coli spp., and enhanced ileal villus height, though other intestinal measures remained unaffected.", "population_specificity": "Weanling pigs (Landrace\u00d7Yorkshire\u00d7Duroc; initial body weight 7.08\u00b10.15 kg).", "effective_dosage": "0%, 0.05%, 0.1%, or 0.15% dietary supplementation.", "study_duration": "Entire experimental period (specific duration not stated in abstract).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:34.525634+00:00"}
{"study_id": 13979, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to examine the cytoprotective effect of Ecklonia cava against oxidative stress in C2C12 myoblasts.", "results_summary": "The ethanol extract of Ecklonia cava (EEEC) protected C2C12 myoblasts from hydrogen peroxide-induced oxidative stress by scavenging reactive oxygen species, reducing DNA damage, and activating the Nrf2-mediated antioxidant pathway, including upregulation of HO-1 and NQO-1 via MAPK signaling.", "population_specificity": "C2C12 myoblasts (a mouse muscle cell line)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:35.063965+00:00"}
{"study_id": 13977, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect of Ecklonia cava polyphenols (ECPs) on human hair growth promotion in vitro and ex vivo.", "results_summary": "Treatment with purified polyphenols from E. cava (PPE) enhanced human dermal papilla cell (hDPC) proliferation by 30.3%, extended hair shaft growth by 30.8%, and increased mRNA expression of growth factors IGF-1 and VEGF while reducing oxidative stress.", "population_specificity": "Human dermal papilla cells (hDPCs) and ex-vivo hair follicle cultures.", "effective_dosage": "0.1 \u00b5g/ml, 3 \u00b5g/ml, 6 \u00b5g/ml, and 10 \u00b5g/ml PPE.", "study_duration": "9 days for hair shaft growth measurement.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:35.133382+00:00"}
{"study_id": 13978, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of a polyphenol-rich fraction of Ecklonia cava (G-CA) on nonalcoholic fatty liver disease (NAFLD) in high-fat diet-fed mice.", "results_summary": "G-CA extract treatment reduced body weight, fat mass, serum biochemical parameters, liver fat, and liver volume in obese mice. It also decreased inflammatory cytokines and hepatic lipogenesis-related genes while increasing bile acid synthesis enzyme (CYP7A1) expression.", "population_specificity": "C57BL6 mice fed a high-fat diet.", "effective_dosage": "300 mg/kg administered by oral intubation.", "study_duration": "10 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:35.454850+00:00"}
{"study_id": 13980, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to examine the anti-aging properties of dieckol (DE) from Ecklonia cava, focusing on free radical scavenging, muscle hypertrophy, cognition-related gene expression, and inhibition of collagenase and elastinase activity.", "results_summary": "The study found that HPE combined with DE (HPE:DE) effectively scavenged free radicals, protected proteins from degradation, inhibited matrix metalloproteinase-1 and protein kinase C alpha expression, reduced elastinase activity, and improved cognition-related gene expression. These effects suggest potential anti-aging benefits.", "population_specificity": "Human fibroblast (CCD986sk), mouse myoblast (C2C12), and neuroblastoma (N2a) cell models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:37.038191+00:00"}
{"study_id": 13981, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine how Ecklonia cava polyphenol (ECP) affects alcohol-metabolizing enzymes and their regulatory mechanisms in ethanol-treated hepatocytes.", "results_summary": "ECP treatment inhibited CYP2E1 expression and activity (linked to ROS production) while increasing ADH and aldehyde dehydrogenase activity, mediated by cyclic AMP-dependent mechanisms. These effects suggest ECP may help prevent ethanol-induced liver injury.", "population_specificity": "Isolated hepatocytes (in vitro study)", "effective_dosage": "Not specified", "study_duration": "0\u201324 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:37.166146+00:00"}
{"study_id": 13983, "supplement_id": 1096, "safety_score": "90", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of a dieckol-rich extract (AG-dieckol) from Ecklonia cava on glycemic parameters, serum biochemistry, and hematology in pre-diabetic adults.", "results_summary": "AG-dieckol supplementation significantly reduced postprandial glucose levels and improved insulin resistance, though no significant difference was observed in insulin and C-peptide levels compared to placebo. No significant adverse events were reported, and biochemical/hematological parameters remained normal.", "population_specificity": "80 pre-diabetic male and female adults.", "effective_dosage": "1500 mg per day.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:40.123933+00:00"}
{"study_id": 13984, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the protective mechanisms of triphlorethol-A from Ecklonia cava against oxidative stress-induced DNA base damage, specifically 8-oxoguanine (8-oxoG), in V79-4 cells.", "results_summary": "Triphlorethol-A significantly reduced 8-oxoG levels induced by H2O2, increased OGG1 mRNA and protein levels, and restored nuclear Nrf2 and Nrf2-Maf complex expression. It also enhanced Nrf2 binding to ARE sequences and OGG1 promoter activity, with PI3K/Akt and Erk pathways implicated in these effects.", "population_specificity": "Chinese hamster lung fibroblast V79-4 cells", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:44.331276+00:00"}
{"study_id": 13987, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the protective effects of 6,6'-bieckol (BEK) from Ecklonia cava against high-glucose-induced oxidative stress in endothelial cells.", "results_summary": "BEK significantly inhibited high-glucose-induced cytotoxicity, reduced oxidative stress markers (TBARS, ROS, nitric oxide), and decreased overexpression of inflammatory proteins (iNOS, COX-2, NF-\u03baB) in HUVECs. These findings suggest BEK may help prevent diabetic endothelial dysfunction.", "population_specificity": "Human umbilical vein endothelial cells (HUVECs) in vitro.", "effective_dosage": "10 or 50 \u03bcg/ml", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:44.547068+00:00"}
{"study_id": 13986, "supplement_id": 1096, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anti-tumor activity of dieckol, a major compound in Ecklonia Cava, and its molecular mechanism in ovarian cancer cells and a xenograft mouse model.", "results_summary": "Dieckol induced apoptosis in ovarian cancer cells, suppressed tumor growth in mice, and activated caspase-dependent apoptosis via ROS production and regulation of AKT and p38 signaling, without significant adverse effects.", "population_specificity": "Ovarian cancer cells (A2780 and SKOV3) and SKOV3 tumor xenograft mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:44.675070+00:00"}
{"study_id": 13985, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Ecklonia cava extract (BKE) could protect human umbilical vein endothelial cells (HUVECs) from high glucose-induced oxidative damage.", "results_summary": "BKE restored cell viability, reduced oxidative stress markers (lipid peroxidation, reactive oxygen species, nitric oxide), and suppressed overexpression of inflammatory proteins (iNOS, COX-2, NF-\u03baB) in HUVECs exposed to high glucose. The effects were dose-dependent.", "population_specificity": "Human umbilical vein endothelial cells (HUVECs) in vitro.", "effective_dosage": "Not specified (dose-dependent effects noted).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:45.282457+00:00"}
{"study_id": 13988, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Ecklonia cava extracts exhibit analgesic effects in rats with postoperative pain and neuropathic pain.", "results_summary": "The study found that Ecklonia cava extracts at 300 mg/kg significantly increased mechanical withdrawal thresholds, reduced ultrasonic distress vocalizations, and improved paw withdrawal latency in hot-and cold-plate tests, suggesting potential analgesic effects in both postoperative and neuropathic pain models.", "population_specificity": "Rats with plantar incision and spared nerve injury (SNI).", "effective_dosage": "300 mg/kg", "study_duration": "15 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:45.283774+00:00"}
{"study_id": 13989, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the mechanism by which dieckol from Ecklonia cava regulates inflammatory responses, specifically its effect on LPS-induced iNOS expression and NF-\u03baB activity.", "results_summary": "Dieckol suppressed LPS-induced iNOS expression, NO production, and NF-\u03baB activity in Raw264.7 cells, reducing p65 nuclear translocation, I\u03baB\u03b1 phosphorylation, and MAPKs phosphorylation, particularly p38MAPK. These findings suggest dieckol negatively regulates inflammatory responses via NF-\u03baB suppression.", "population_specificity": "Mouse leukemic macrophage Raw264.7 cells", "effective_dosage": "Dose-dependent manner (specific amounts not provided)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:45.895360+00:00"}
{"study_id": 13990, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the molecular characteristics and immunomodulating activities of sulfated fucans isolated from Ecklonia cava.", "results_summary": "The study found that purified fractions of Ecklonia cava, particularly EF2, significantly stimulated immune responses in RAW264.7 cells, including nitric oxide and cytokine production, likely through NF-\u03baB and MAPK pathway activation. The molecular weights and compositions of the fractions varied, with EF2 showing the highest immunoenhancing properties.", "population_specificity": "RAW264.7 cells (a murine macrophage cell line)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:48.577195+00:00"}
{"study_id": 13993, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the in vivo anti-inflammatory effects of fucoidan extracted from Ecklonia cava (ECF) using zebrafish models.", "results_summary": "ECF inhibited ROS and NO generation induced by tail-cutting and LPS-treatment in zebrafish, demonstrating anti-inflammatory activity. It also showed a protective effect against LPS-induced toxicity in zebrafish embryos.", "population_specificity": "Zebrafish (tail-cutting and LPS-stimulated models) and zebrafish embryos.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:51.899453+00:00"}
{"study_id": 13991, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of Ecklonia cava and its component dioxinodehydroeckol on hair-shaft growth in human hair follicles and hair growth in mice.", "results_summary": "The study found that Ecklonia cava's ethyl acetate-soluble fraction (EAFE) and dioxinodehydroeckol promoted hair-shaft elongation in cultured human hair follicles, stimulated hair follicle cell proliferation, and induced anagen phase transition in mice, likely through increased IGF-1 expression.", "population_specificity": "Human dermal papilla cells (DPCs), outer root sheath (ORS) cells, and C57BL/6 mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:53.259741+00:00"}
{"study_id": 13995, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the mechanism by which Ecklonia cava reduces beta-amyloid (A\u03b2) production in Alzheimer's disease by examining its effects on alpha-, beta-, and gamma-secretase expression and activity.", "results_summary": "The study found that Ecklonia cava extract activated alpha-secretase while reducing gamma-secretase activity and expression, leading to decreased A\u03b2 production. The extract also affected the nuclear location of PSEN1, though the significance of this finding remains unclear.", "population_specificity": "HEK293 cells expressing the APP Swedish mutation (in vitro study).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:54.474438+00:00"}
{"study_id": 13994, "supplement_id": 1096, "safety_score": "90", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the efficacy and safety of Ecklonia cava polyphenol (Seapolynol\u2122) in individuals with hypercholesterolemia, with a subgroup analysis for metabolic syndrome (MetS).", "results_summary": "The study found significant reductions in hip circumference, total cholesterol, LDL-C, and C-reactive protein after 12 weeks of Seapolynol treatment, with no significant adverse effects. Hb(A1c) decreased notably in the MetS(+) group compared to the MetS(-) group.", "population_specificity": "Individuals with hypercholesterolemia (fasting total cholesterol >240 mg/dL or LDL-C >130 mg/dL), including a subgroup with metabolic syndrome (MetS).", "effective_dosage": "400 mg orally once daily", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:54.951698+00:00"}
{"study_id": 13996, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the protective effects of dieckol, a compound from Ecklonia cava, against high glucose-induced oxidative stress and apoptosis in rat insulinoma cells.", "results_summary": "Dieckol significantly inhibited high glucose-induced glucotoxicity, reduced oxidative stress markers (TBARS, ROS, nitric oxide), and increased antioxidative enzyme activities (CAT, SOD, GSH-px). It also suppressed apoptosis by modulating Bcl-2 and cleaved caspase-3 expression.", "population_specificity": "Rat insulinoma cells (in vitro study)", "effective_dosage": "17.5 \u00b5M and 70 \u00b5M", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:55.032288+00:00"}
{"study_id": 13992, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antiviral activity of five phlorotannins isolated from Ecklonia cava against porcine epidemic diarrhea virus (PEDV).", "results_summary": "Compounds 2-5 showed antiviral activity by blocking viral binding to cells, with IC\u2085\u2080 values ranging from 10.8 \u00b1 1.4 to 22.5 \u00b1 2.2 \u03bcM. Compounds 4 and 5 also inhibited viral replication with IC\u2085\u2080 values of 12.2 \u00b1 2.8 and 14.6 \u00b1 1.3 \u03bcM, respectively, by targeting viral RNA and protein synthesis.", "population_specificity": "In vitro study (no human or animal subjects specified beyond cell-based assays).", "effective_dosage": "Concentrations ranging from 10.8 \u00b1 1.4 to 36.6 \u03bcM.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:55.198094+00:00"}
{"study_id": 13997, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of Ecklonia Cava extracts on diet-induced obesity and type 2 diabetes in mice, focusing on body weight, fat content, hyperglycemia, and underlying mechanisms.", "results_summary": "G-CA (Ecklonia Cava from Gijang) reduced body weight gain, body fat, and hyperglycemia, improved glucose tolerance, increased adipogenic gene expression, and decreased inflammatory cytokine expression in obese mice.", "population_specificity": "C57BL/6 male mice fed a high-fat diet.", "effective_dosage": "200 mg/kg administered by oral intubation.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:57.306842+00:00"}
{"study_id": 13998, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Ecklonia cava polyphenols (ECP) exhibit neuroprotective effects in focal brain ischemia and the mechanisms underlying these effects.", "results_summary": "ECP administration significantly reduced infarct size, brain edema, and neuronal apoptosis in rats with induced focal ischemia, while also improving neurobehavioral outcomes. In vitro, ECP demonstrated neuroprotective effects by reducing oxidative stress and blocking calcium-mediated neurotoxicity.", "population_specificity": "Rats with induced transient focal ischemia (MCAO model) and differentiated SH-SY5Y neuroblastoma cells.", "effective_dosage": "10 mg/kg and 50 mg/kg intraperitoneally (i.p.)", "study_duration": "6 days post-MCAO for neurobehavioral tests; in vitro duration not specified.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:02.841118+00:00"}
{"study_id": 14002, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anti-diabetic and hypolipidemic effects of Ecklonia cava in streptozotocin-induced diabetic mice.", "results_summary": "EC supplementation significantly reduced serum glucose and improved insulin secretion, while also lowering triglyceride and cholesterol levels. It also prevented \u03b2-cell mass loss and ameliorated liver steatosis in diabetic mice.", "population_specificity": "Streptozotocin-induced diabetic mice", "effective_dosage": "3% and 5% EC diet", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:03.043008+00:00"}
{"study_id": 14001, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Ecklonia cava hydrolysate (EHE) protects INS-1 pancreatic \u03b2-cells from high glucose-induced oxidative damage and apoptosis.", "results_summary": "EHE restored cell viability, reduced oxidative stress markers (lipid peroxidation, ROS, NO), enhanced antioxidant enzyme activity (CAT, SOD, GSH-px), and modulated apoptosis-related proteins (reduced Bax, increased Bcl-2) in high glucose-treated INS-1 cells.", "population_specificity": "INS-1 pancreatic \u03b2-cells (in vitro study)", "effective_dosage": "Not specified (dose-dependent effects observed)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:03.729632+00:00"}
{"study_id": 13982, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the potential of polyphenols isolated from Ecklonia cava as drug candidates for Alzheimer's disease, focusing on their inhibitory activities against key enzymes and pathways involved in the disease.", "results_summary": "The study found that five polyphenols from Ecklonia cava exhibited moderate to potent inhibitory activities against acetylcholinesterase, butyrylcholinesterase, glycogen synthase kinase 3 beta, and \u03b2-secretase, with phlorofucofuroeckol-A (PFF-A) showing particularly strong effects. These compounds also inhibited amyloid precursor protein biosynthesis, suggesting potential as Alzheimer's disease therapeutics.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified (IC50 values provided: 0.95\u201396.3 \u03bcM)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:04.075153+00:00"}
{"study_id": 14003, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Ecklonia cava polyphenol (ECP) could prevent ethanol-induced liver injury in hepatocytes, hepatic stellate cells, and rats.", "results_summary": "ECP treatment suppressed ethanol-induced cell death in hepatocytes and reduced collagen and \u03b1-smooth muscle actin expression in hepatic stellate cells. In rats, ECP lowered serum AST and ALT activity and fully protected against ethanol- and CCl4-induced liver injury.", "population_specificity": "Male Wistar rats and isolated hepatocytes and hepatic stellate cells.", "effective_dosage": "0.02% or 0.2% ECP in diet.", "study_duration": "3 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:04.666877+00:00"}
{"study_id": 14004, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Ecklonia cava extract (ECE) could suppress high glucose-induced activation of hepatic stellate cells (HSCs), a key factor in diabetic liver fibrosis.", "results_summary": "ECE suppressed high glucose-induced activation of HSCs by inhibiting reactive oxygen species (ROS) formation, restoring glutathione levels, and downregulating TGF-\u03b2 secretion, suggesting potential for preventing diabetic liver fibrosis.", "population_specificity": "Isolated hepatic stellate cells (HSCs) treated with high glucose concentrations.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:05.325935+00:00"}
{"study_id": 14005, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the mechanism by which dieckol from Ecklonia cava exerts its antitumor activity, specifically its effects on cancer cell migration and invasion.", "results_summary": "Dieckol inhibited migration and invasion of HT1080 cells by scavenging intracellular ROS, attenuating Rac1 activation, and downregulating FAK signaling and MMP expression. These findings suggest dieckol may suppress cancer progression and metastasis.", "population_specificity": "HT1080 human fibrosarcoma cells (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:11.092428+00:00"}
{"study_id": 14006, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the depressive effects of Ecklonia cava (EC) on the central nervous system (CNS), focusing on its anticonvulsive and sleep-inducing properties.", "results_summary": "The study found that EC enzymatic extract (ECEE) and its phlorotannin-rich fraction (PTRF) showed significant anticonvulsive and sleep-inducing effects in mice, mediated by positive modulation of GABA(A)-BZD receptors, similar to diazepam.", "population_specificity": "Mice (animal study)", "effective_dosage": "ECEE (>500 mg/kg), PTRF (>50 mg/kg)", "study_duration": "Not specified", "interactions": "Flumazenil blocked the sleep-inducing effects of ECEE and PTRF.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:12.208855+00:00"}
{"study_id": 14007, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the anti-metastatic effects of Ecklonia cava extract (ECE) on A549 human lung carcinoma cells, focusing on migration, invasion, and related signaling pathways.", "results_summary": "ECE significantly suppressed migration and invasion of A549 cells in a concentration-dependent manner, down-regulated MMP-2 activity, and inhibited Akt and p38 signaling pathways, suggesting therapeutic potential for metastatic lung cancer.", "population_specificity": "A549 human lung adenocarcinoma cells (in vitro study).", "effective_dosage": "Not specified (concentration-dependent effects noted).", "study_duration": "Not specified (time-dependent effects noted).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:13.129886+00:00"}
{"study_id": 14009, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Ecklonia Cava extracts exhibit anti-inflammatory effects in human endothelial cells and to elucidate the molecular mechanisms involved.", "results_summary": "The study found that Ecklonia Cava extracts inhibited LPS-induced barrier permeability, reduced expression of cell adhesion molecules, and suppressed monocyte adhesion and migration. The extracts also decreased TNF-alpha production and NF-kappaB activation, with ethyl acetate and butanol extracts showing superior anti-inflammatory effects.", "population_specificity": "Human endothelial cells (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:13.132141+00:00"}
{"study_id": 13999, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of Ecklonia cava enzymatic extract, particularly dieckol, on hair growth promotion through DPC proliferation and 5\u03b1-reductase inhibition.", "results_summary": "The study found that Ecklonia cava enzymatic extract increased hair-fiber length in vibrissa follicles, induced anagen progression in mice, and promoted DPC proliferation. Dieckol specifically inhibited 5\u03b1-reductase activity, suggesting a dual mechanism for hair growth stimulation.", "population_specificity": "Vibrissa follicles, C57BL/6 mice, immortalized vibrissa dermal papilla cells (DPC), and NIH3T3 fibroblasts.", "effective_dosage": "0.5% E. cava enzymatic extract (topical application).", "study_duration": "21 days (in vitro), duration in mice not specified.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:13.752920+00:00"}
{"study_id": 14010, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Ecklonia cava enzymatic digest (ECC) could protect Human umbilical vein endothelial cells (HUVECs) from high glucose-induced oxidative stress, a condition associated with diabetes.", "results_summary": "ECC significantly reduced high glucose-induced cytotoxicity, oxidative stress markers (TBARS, reactive oxygen species, nitric oxide), and overexpression of inflammatory proteins (iNOS, COX-2, NF-\u03baB), while increasing antioxidant enzyme activity in HUVECs.", "population_specificity": "Human umbilical vein endothelial cells (HUVECs) in vitro.", "effective_dosage": "10 or 100 \u00b5g/mL", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:14.041292+00:00"}
{"study_id": 14008, "supplement_id": 1096, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to determine the effects of a polyphenol extract from Ecklonia cava (ECP) on anthropometry, serum biochemistry, and hematology in overweight adults.", "results_summary": "Both low-dose (72 mg/day) and high-dose (144 mg/day) ECP groups showed significant reductions in BMI, body fat ratio, waist circumference, and lipid parameters compared to placebo. The high-dose group also exhibited increased HDL cholesterol and reduced serum glucose and systolic blood pressure, with no significant adverse events reported.", "population_specificity": "Overweight male and female adults (average age 40.5 \u00b1 9.2 years, BMI 26.5 \u00b1 1.6 kg/m\u00b2).", "effective_dosage": "72 mg/day (low-dose) and 144 mg/day (high-dose).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:14.238565+00:00"}
{"study_id": 14011, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the antidiabetic therapeutic effect of Ecklonia cava in type 1 diabetes mellitus rats and C2C12 myoblasts.", "results_summary": "The methanol extract of Ecklonia cava (ECM) significantly reduced plasma glucose levels, increased insulin concentration, and improved diabetic symptoms like polyphagia and polydipsia in rats. The mechanism involved activation of AMP-activated protein kinase/ACC and PI-3 kinase/Akt pathways.", "population_specificity": "Streptozotocin-induced type 1 diabetes mellitus rats and C2C12 myoblasts.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:20.178648+00:00"}
{"study_id": 14012, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether dieckol, a compound from Ecklonia cava, could protect human umbilical vein endothelial cells (HUVECs) from high glucose-induced oxidative stress.", "results_summary": "Dieckol significantly reduced high glucose-induced cytotoxicity, oxidative stress markers (TBARS, ROS, nitric oxide), and overexpression of inflammatory proteins (iNOS, COX-2, NF-kB) in HUVECs. The effects were dose-dependent, suggesting therapeutic potential for diabetes-related oxidative damage.", "population_specificity": "Human umbilical vein endothelial cells (HUVECs) in vitro.", "effective_dosage": "10 or 50 \u00b5g/ml", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:21.021606+00:00"}
{"study_id": 14015, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Ecklonia Cava (EC) pretreatment inhibits anti-inflammatory activity in LPS-stimulated murine BV2 microglia and to elucidate the underlying molecular mechanisms.", "results_summary": "EC inhibited LPS-induced NO and PGE(2) production, reduced NF-kappaB translocation and DNA-binding, and suppressed proinflammatory cytokines by blocking NF-kappaB and MAPK activation, demonstrating significant anti-inflammatory effects without cytotoxicity.", "population_specificity": "Murine BV2 microglia cells", "effective_dosage": "Concentration-dependent (specific amounts not provided)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:22.198993+00:00"}
{"study_id": 14013, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anti-proliferative and apoptotic effects of phloroglucinol derivatives from Ecklonia Cava on human breast cancer cells.", "results_summary": "Compound 1 from Ecklonia Cava showed higher anti-proliferative activity and induced apoptosis in MCF-7 human breast cancer cells in a dose-dependent manner, involving caspase activation, PARP cleavage, and modulation of apoptotic and NF-kappaB-related genes.", "population_specificity": "MCF-7 human breast cancer cells (in vitro study).", "effective_dosage": "Not specified (dose-dependent effects noted).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:22.770370+00:00"}
{"study_id": 14016, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Ecklonia Cava extract (ECK) has immunological effects on splenocytes in vitro and its potential to modulate immune responses.", "results_summary": "ECK significantly increased splenocyte proliferation, elevated lymphocyte, monocyte, and granulocyte counts, and modulated cytokine production by downregulating Th1-type cytokines (TNF-alpha, IFN-gamma) and upregulating Th2-type cytokines (IL-4, IL-10). These findings suggest ECK has immunomodulatory properties favoring anti-inflammatory responses.", "population_specificity": "ICR mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:23.534338+00:00"}
{"study_id": 14017, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Ecklonia Cava (EC) extract could inhibit asthmatic reactions in a mouse model of asthma.", "results_summary": "EC extract significantly inhibited asthmatic reactions, including inflammatory cell influx, airway hyperresponsiveness, and Th2 cytokine production, without increasing Th1 cytokines. It also reduced MMP-9, SOCS-3 expression, and eosinophil peroxidase activity.", "population_specificity": "OVA-sensitized and challenged mice (asthma model).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:23.650275+00:00"}
{"study_id": 14014, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the feasibility of phlorotannins from Ecklonia cava as inhibitors of melanin formation by evaluating their effects on tyrosinase activity and melanin production in B16F10 melanoma cells.", "results_summary": "The study found that 7-phloroeckol, a phlorotannin from Ecklonia cava, showed potent tyrosinase inhibitory effects (IC50 = 0.85 \u03bcM) and significantly reduced melanin production in B16F10 cells at concentrations of 6.25-100 \u03bcM, outperforming positive controls like arbutin and kojic acid.", "population_specificity": "B16F10 melanoma cells (in vitro study)", "effective_dosage": "50 \u03bcg/mL for tyrosinase inhibition; 6.25-100 \u03bcM for melanin inhibition", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:23.951569+00:00"}
{"study_id": 14000, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of Ecklonia Cava on intestinal glucose uptake, SGLT1 protein expression, and insulin secretion in diabetic conditions.", "results_summary": "Ecklonia Cava inhibited intestinal glucose uptake and downregulated SGLT1 protein expression, enhanced insulin secretion in pancreatic \u03b2-islet cells, and improved postprandial glucose regulation in diabetic mice.", "population_specificity": "Streptozotocin (STZ)-induced diabetic mice", "effective_dosage": "IC50 value of 345 \u03bcg/mL for methanol extract (specific dosage not detailed for in vivo study)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:25.069403+00:00"}
{"study_id": 14018, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the potential therapeutic effects of Ecklonia cava phlorotannin-rich extracts, particularly ventol, on osteoarthritis by examining antioxidative and anti-inflammatory mechanisms.", "results_summary": "The study found that Ecklonia cava extracts, including ventol, exhibited significant antioxidant activities and downregulated PGE2 generation, suggesting potential benefits in mitigating osteoarthritis-related inflammation and cartilage degradation. Ventol also inhibited proteoglycan degradation induced by interleukin-1alpha, indicating therapeutic promise for osteoarthritis.", "population_specificity": "In vitro studies using RAW 246.7 cells and human recombinant interleukin-1alpha-induced models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:29.394126+00:00"}
{"study_id": 14019, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the potential therapeutic effects of Ecklonia cava-derived phlorotannins, particularly LAD103, on osteoarthritis by examining their antioxidant and anti-inflammatory properties.", "results_summary": "The study found that LAD103 exhibited significant antioxidant activities, downregulated PGE2 generation, and inhibited proteoglycan degradation, suggesting potential benefits in osteoarthritis management. However, further mechanistic and efficacy studies are needed.", "population_specificity": "In vitro studies using RAW 246.7 cells and human recombinant interleukin-1alpha-induced models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:30.143060+00:00"}
{"study_id": 187624, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the sedative-hypnotic effects of Ecklonia Cava's phlorotannins, particularly their interaction with the GABA-A-benzodiazepine receptor.", "results_summary": "The study suggests that phlorotannins from Ecklonia Cava exhibit sedative-hypnotic effects, potentially aiding sleep through GABA-A receptor modulation. However, specific clinical outcomes or comparative efficacy data are not detailed in the abstract.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not provided in the abstract.", "study_duration": "Not provided in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:30.978483+00:00"}
{"study_id": 65383, "supplement_id": 1097, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to assess the impact of daily egg consumption on linear growth among 6-12-month-old infants in rural Bangladesh.", "results_summary": "Daily egg consumption for 6 months improved weight and weight-for-age z-scores but did not significantly affect linear growth or stunting prevalence in infants.", "population_specificity": "6-12-month-old infants in rural Bangladesh.", "effective_dosage": "Daily egg.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:31.532981+00:00"}
{"study_id": 65382, "supplement_id": 1097, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to analyze the methodological parameters of OVA-induced asthma models in mice to understand how factors like dosage and exposure method impact study outcomes.", "results_summary": "The study found that parameters such as OVA sensitization dose, challenge dose, and alum/sensitization ratio significantly influence lung resistance in asthma models, but standardized criteria are lacking.", "population_specificity": "Murine (mouse) experimental models", "effective_dosage": "Not specified (data extracted from seven studies but exact dosages not detailed in abstract)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:32.014980+00:00"}
{"study_id": 187625, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antidiabetic, antihyperlipidemic, and anti-inflammatory effects of marine polyphenols, including those from Ecklonia cava, in humans.", "results_summary": "Supplementation with polyphenol-rich extracts showed small-to-medium positive effects on fasting blood glucose, total cholesterol, and LDL-cholesterol, but the evidence was insufficient to confirm consistent effects.", "population_specificity": "271 human adults (one postprandial cross-over trial and four parallel design trials).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:32.434933+00:00"}
{"study_id": 187628, "supplement_id": 1096, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the acute effects of Ecklonia cava polyphenol (ECP) supplementation on maximum endurance capacity and related physiological parameters during intense exercise.", "results_summary": "ECP supplementation increased time to exhaustion by 2.39 minutes and showed a 6.5% higher mean VO2max (though not statistically significant). Blood glucose levels post-exercise were significantly higher (+9.9%) in the ECP group, while lactate levels showed a decreasing trend (nonsignificant).", "population_specificity": "20 men aged 18-23 years.", "effective_dosage": "Not specified.", "study_duration": "Acute (single dose 30 minutes before exercise).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:32.772499+00:00"}
